Institut Pasteur publications about SARS-CoV-2 / Covid-19
© Institut Pasteur
The Institut Pasteur’s list of scientific publications on SARS-CoV-2 coronavirus and Covid-19 disease.
| Title | Author | Date | Source | Publication |
|---|---|---|---|---|
| Differential prevalence and risk factors for infection with coronaviruses in bats collected from Yunnan Province, China | Li R. et al. | 2024 | One Health 19, 100923 | 10.1016/j.onehlt.2024.100923 |
| International congress on transposable elements (ICTE 2024) in Saint Malo: breaking down transposon waves and their impact | Lesage P. et al. | 2024 | Mobile DNA 15 (1), 25 | 10.1186/s13100-024-00334-9 |
| Emergence of the B.1.214.2 SARS-CoV-2 lineage with an Omicron-like spike insertion and a unique upper airway immune signature | Holtz A. et al. | 2024 | BMC Infectious Diseases 24 (1), 1139 | 10.1186/s12879-024-09967-w |
| Evolutionary origin and population diversity of a cryptic hybrid pathogen | Steenwyk J.L. et al. | 2024 | Nature Communications 15 (1), 8412 | 10.1038/s41467-024-52639-1 |
| The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021–2022 influenza season | Bricout H. et al. | 2024 | Clinical Microbiology and Infection 30 (12), pp. 1592-1598 | 10.1016/j.cmi.2024.08.012 |
| Longitudinal genomic analysis of Neisseria gonorrhoeae transmission dynamics in Australia | Taouk M.L. et al. | 2024 | Nature Communications 15 (1), 8076 | 10.1038/s41467-024-52343-0 |
| Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020–2022 | Galmiche S. et al. | 2024 | BMC Public Health 24 (1), 2411 | 10.1186/s12889-024-19651-y |
| Interplay between host humoral pattern recognition molecules controls undue immune responses against Aspergillus fumigatus | Dellière S. et al. | 2024 | Nature Communications 15 (1), 6966 | 10.1038/s41467-024-51047-9 |
| Recent increase in atypical presentations of invasive meningococcal disease in France | Taha S. ; Deghmane A.E. ; Taha M.K. | 2024 | BMC Infectious Diseases 24 (1), 640 | 10.1186/s12879-024-09547-y |
| Correction to: Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan (BMC Infectious Diseases, (2024), 24, 1, (542), 10.1186/s12879-024-09427-5) | Takayama Y. et al. | 2024 | BMC Infectious Diseases 24 (1), 621 | 10.1186/s12879-024-09533-4 |
| Dynamic label-free analysis of SARS-CoV-2 infection reveals virus-induced subcellular remodeling | Saunders N. et al. | 2024 | Nature Communications 15 (1), 4996 | 10.1038/s41467-024-49260-7 |
| Assessment of fever screening at airports in detecting domestic passengers infected with SARS-CoV-2, 2020–2022, Okinawa prefecture, Japan | Takayama Y. et al. | 2024 | BMC Infectious Diseases 24 (1), 542 | 10.1186/s12879-024-09427-5 |
| Increased levels of GM-CSF and CXCL10 and low CD8+ memory stem T Cell count are markers of immunosenescence and severe COVID-19 in older people | Poisson J. et al. | 2024 | Immunity and Ageing 21 (1), 28 | 10.1186/s12979-024-00430-7 |
| Direct impact of COVID-19 vaccination in Chile: averted cases, hospitalizations, ICU admissions, and deaths | Brault A. et al. | 2024 | BMC Infectious Diseases 24 (1), 467 | 10.1186/s12879-024-09304-1 |
| The hinge-engineered IgG1-IgG3 hybrid subclass IgGh | Izadi A. et al. | 2024 | Nature Communications 15 (1), 3600 | 10.1038/s41467-024-47928-8 |
| Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion | Planas D. et al. | 2024 | Nature Communications 15 (1), 2254 | 10.1038/s41467-024-46490-7 |
| SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave | Pouquet M. et al. | 2024 | Scientific Reports 14 (1), 5418 | 10.1038/s41598-024-55477-9 |
| Assessing respiratory epidemic potential in French hospitals through collection of close contact data (April–June 2020) | Shirreff G. et al. | 2024 | Scientific Reports 14 (1), 3702 | 10.1038/s41598-023-50228-8 |
| SARS-CoV-2 seroprevalence and associated factors of infection before and after the Delta wave in French Polynesia: a cross-sectional study | Mendiboure V. et al. | 2024 | BMC Public Health 24 (1) | 10.1186/s12889-024-17869-4 |
| Effectiveness of XBB.1.5 Vaccines Against Symptomatic SARS-CoV-2 Infection in Older Adults During the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024 | Merdrignac L. et al. | 2024 | Influenza and other Respiratory Viruses 18 (11), e70009 | 10.1111/irv.70009 |
| Comparison of SARS-COV-2 humoral response between rheumatoid arthritis, psoriatic arthritis and spondyloarthritis patients and controls in two unvaccinated cohorts | Ruyssen-Witrand A. et al. | 2024 | Clinical and Experimental Rheumatology 42 (11), pp. 2141-2149 | 10.55563/clinexprheumatol/48440j |
| SARS-CoV-2 Infection in School Settings, Okinawa Prefecture, Japan, 2021–2022 | Takayama Y. et al. | 2024 | Emerging Infectious Diseases 30 (11), pp. 2343-2351 | 10.3201/eid3011.240638 |
| Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France | Sabaté-Elabbadi A. et al. | 2024 | Journal of Infection 89 (5), 106287 | 10.1016/j.jinf.2024.106287 |
| Genetic variations in Interferon-Induced with Helicase C Domain 1: Impact on COVID-19 risk and severity in the Moroccan population | Aqillouch S. et al. | 2024 | Human Immunology 85 (6), 111149 | 10.1016/j.humimm.2024.111149 |
| Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov) | Araujo-Chaveron L. ; Olivier C. ; Pellissier G. ; Bouvet E. ; Mueller J.E. | 2024 | Vaccine 42 (24), 126103 | 10.1016/j.vaccine.2024.07.004 |
| Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boosting | Jeger-Madiot R. et al. | 2024 | Journal of Experimental Medicine 221 (10), e20240289 | 10.1084/jem.20240289 |
| Corrigendum to “Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: results from the VEBIS primary care test-negative design study, September 2023–January 2024” [Vaccine 42(19) (2024)] (Vaccine (2024) 42(19) (3931–3937), (S0264410X24006443), (10.1016/j.vaccine.2024.05.067)) | Laniece Delaunay C. et al. | 2024 | Vaccine 42 (23), 126089 | 10.1016/j.vaccine.2024.06.056 |
| Pediatric Hospitalizations and Emergency Department Visits Related to Mental Health Conditions and Self-Harm | Valtuille Z. et al. | 2024 | JAMA network open 7 (10), pp. e2441874 | 10.1001/jamanetworkopen.2024.41874 |
| Recent evolution of the epidemiology and burden of invasive meningococal disease | Taha S. ; Deghmane A.E. | 2024 | La Revue du praticien 74 (8), pp. s7-s10 | |
| Seasonality and Co-Detection of Respiratory Viral Infections Among Hospitalised Patients Admitted With Acute Respiratory Illness—Valencia Region, Spain, 2010–2021 | Shirreff G. et al. | 2024 | Influenza and other Respiratory Viruses 18 (10), e70017 | 10.1111/irv.70017 |
| The Model for End-Stage Liver Disease (MELD) Score Predicting Mortality Due to SARS-CoV-2 in Mexican Patients | Reyes-Ruiz J.M. et al. | 2024 | Journal of Clinical Medicine 13 (19), 5777 | 10.3390/jcm13195777 |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells | Beaumont E. ; Müller-Trutwin M. ; Huot N. | 2024 | Genes and Immunity 25 (5), pp. 443-445 | 10.1038/s41435-024-00284-5 |
| Escape of SARS-CoV-2 Variants KP1.1, LB.1, and KP3.3 From Approved Monoclonal Antibodies | Planas D. et al. | 2024 | Pathogens and Immunity 10 (1), pp. 1-11 | 10.20411/pai.v10i1.752 |
| Antigenic sin and multiple breakthrough infections drive converging evolution of COVID-19 neutralizing responses | Paciello I. et al. | 2024 | Cell Reports 43 (9), 114645 | 10.1016/j.celrep.2024.114645 |
| Preschool-age children maintain a distinct memory CD4+ T cell and memory B cell response after SARS-CoV-2 infection | Manfroi B. et al. | 2024 | Science translational medicine 16 (765), pp. eadl1997 | 10.1126/scitranslmed.adl1997 |
| Immune system adaptation during gender-affirming testosterone treatment | Lakshmikanth T. et al. | 2024 | Nature 633 (8028), pp. 155-164 | 10.1038/s41586-024-07789-z |
| Levels and functionality of Pacific Islanders’ hybrid humoral immune response to BNT162b2 vaccination and delta/omicron infection: A cohort study in New Caledonia | Inizan C. et al. | 2024 | PLoS Medicine 21 (9), e1004397 | 10.1371/journal.pmed.1004397 |
| Multiple Mechanisms of Action of Sulfodyne®, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection | Romeo P.H. et al. | 2024 | Antioxidants 13 (9), 1083 | 10.3390/antiox13091083 |
| Understanding emerging and re-emerging viruses to facilitate pandemic preparedness | Zapatero-Belinchón F.J. ; Kumar P. ; Ott M. ; Schwartz O. ; Sigal A. | 2024 | Nature Microbiology 9 (9), pp. 2208-2211 | 10.1038/s41564-024-01789-5 |
| Phylogeography of horseshoe bat sarbecoviruses in Vietnam and neighbouring countries. Implications for the origins of SARS-CoV and SARS-CoV-2 | Hassanin A. et al. | 2024 | Molecular Ecology 33 (18), e17486 | 10.1111/mec.17486 |
| Zanamivir and baloxavir combination to cure persistent influenza and coronavirus infections after hematopoietic stem cell transplant | Euzen V. et al. | 2024 | International Journal of Antimicrobial Agents 64 (3), 107281 | 10.1016/j.ijantimicag.2024.107281 |
| Endolysosomal channel TMEM175 mediates antitoxin activity of DABMA | Wu Y. et al. | 2024 | FEBS Journal 291 (18), pp. 4142-4154 | 10.1111/febs.17242 |
| Contributions of the qualitative Qualicor study embedded in a cohort study on the circumstances of SARS-CoV 2 infection in France | Perrey C. et al. | 2024 | Infectious Diseases Now 54 (6), 104943 | 10.1016/j.idnow.2024.104943 |
| An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution | Subissi L. et al. | 2024 | Nature Medicine 30 (9), pp. 2400-2403 | 10.1038/s41591-024-02949-0 |
| Systems vaccinology studies – achievements and future potential | Sugrue J.A. ; Duffy D. | 2024 | Microbes and Infection 26 (7), 105318 | 10.1016/j.micinf.2024.105318 |
| Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses | Maestri R. ; Perez-Lamarque B. ; Zhukova A. ; Morlon H. | 2024 | eLife 13 | 10.7554/eLife.91745 |
| Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera | Eliadis P. et al. | 2024 | Vaccines 12 (8), 914 | 10.3390/vaccines12080914 |
| Resurgence of Bordetella pertussis, including one macrolide-resistant isolate, France, 2024 | Rodrigues C. et al. | 2024 | Eurosurveillance 29 (31), 2400459 | 10.2807/1560-7917.ES.2024.29.31.2400459 |
| Agreement between two real-time commercial PCR kits and an in-house real-time PCR for diagnosis of mucormycosis | Rafanomezantsoa L.C. et al. | 2024 | Microbiology Spectrum 12 (8) | 10.1128/spectrum.03585-23 |
| Routes of SARS-Cov2 transmission in the intensive care unit: A multicentric prospective study | Tandjaoui-Lambiotte Y. et al. | 2024 | Journal of Infection and Public Health 17 (8), 102454 | 10.1016/j.jiph.2024.05.042 |
| Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination | Durier C. et al. | 2024 | Infectious Diseases Now 54 (5), 104886 | 10.1016/j.idnow.2024.104886 |
| Environmental variation and genetic diversity contribute to population differences in immune responses to SARS-CoV-2 and COVID-19 risk | Rotival M. ; Quintana-Murci L. | 2024 | Genes and Immunity 25 (4), pp. 338-340 | 10.1038/s41435-023-00249-0 |
| Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024 | Laniece Delaunay C. et al. | 2024 | Vaccine 42 (19), pp. 3931-3937 | 10.1016/j.vaccine.2024.05.067 |
| Broad sarbecovirus neutralization by combined memory B cell antibodies to ancestral SARS-CoV-2 | Planchais C. et al. | 2024 | iScience 27 (7), 110354 | 10.1016/j.isci.2024.110354 |
| The RBPome of influenza A virus NP-mRNA reveals a role for TDP-43 in viral replication | Dupont M. et al. | 2024 | Nucleic Acids Research 52 (12), pp. 7188-7210 | 10.1093/nar/gkae291 |
| Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway | Mitri C. et al. | 2024 | Microbes and Infection 26 (5-6), 105354 | 10.1016/j.micinf.2024.105354 |
| Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19 | Cavaillon J.M. ; Chousterman B.G. ; Skirecki T. | 2024 | Journal of Intensive Medicine 4 (3), pp. 326-340 | 10.1016/j.jointm.2024.01.001 |
| High-throughput screening identifies broad-spectrum Coronavirus entry inhibitors | Khan S. et al. | 2024 | iScience 27 (6), 110019 | 10.1016/j.isci.2024.110019 |
| Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study | Funk A. et al. | 2024 | Clinical Infectious Diseases 78 (6), pp. 1522-1530 | 10.1093/cid/ciae069 |
| The mission of COVARS: how to anticipate health risks within a "One Health" vision of the exposome | Autran B. et al. | 2024 | Medecine/Sciences 40 (6-7), pp. 485-486 | 10.1051/medsci/2024098 |
| Virological characteristics of a SARS-CoV-2-related bat coronavirus, BANAL-20-236 | Fujita S. et al. | 2024 | eBioMedicine 104, 105181 | 10.1016/j.ebiom.2024.105181 |
| A seroprevalence study of SARS-CoV-2 and seasonal coronaviruses after the first SARS-CoV-2 circulation in New Caledonia, Pacific region | Huet K. et al. | 2024 | IJID Regions 11, 100373 | 10.1016/j.ijregi.2024.100373 |
| Influence of COVID-19 on trust in routine immunization, health information sources and pandemic preparedness in 23 countries in 2023 | Lazarus J.V. et al. | 2024 | Nature Medicine 30 (6), pp. 1559-1563 | 10.1038/s41591-024-02939-2 |
| Characteristics and incidence of infections in patients with multiple myeloma treated by bispecific antibodies: a national retrospective study | Jourdes A. et al. | 2024 | Clinical Microbiology and Infection 30 (6), pp. 764-771 | 10.1016/j.cmi.2024.02.023 |
| Redefining pandemic preparedness: Multidisciplinary insights from the CERP modelling workshop in infectious diseases, workshop report | Nunes M.C. et al. | 2024 | Infectious Disease Modelling 9 (2), pp. 501-518 | 10.1016/j.idm.2024.02.008 |
| Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial | Thilly N. et al. | 2024 | JAMA Network Open 7 (5), e2411938 | 10.1001/jamanetworkopen.2024.11938 |
| Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France | Lièvre G. et al. | 2024 | Vaccine 42 (14), pp. 3288-3299 | 10.1016/j.vaccine.2024.04.024 |
| A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease | Nambulli S. et al. | 2024 | Journal of virology 98 (5), pp. e0176223 | 10.1128/jvi.01762-23 |
| Geographic heterogeneity of SARS-CoV-2 circulation in Abidjan, Ivory Coast: a prospective study | Doumbia M. ; Sevede D. ; Kouakou V. ; Pineau P. | 2024 | Journal of Infection in Developing Countries 18 (5), pp. 679-686 | 10.3855/jidc.17675 |
| Emergence failure of early epidemics: A mathematical modeling approach | Breban R. | 2024 | PLoS ONE 19 (5 May), e0301415 | 10.1371/journal.pone.0301415 |
| Snapshot of Anti-SARS-CoV-2 IgG Antibodies in COVID-19 Recovered Patients in Guinea | Grayo S. et al. | 2024 | Journal of Clinical Medicine 13 (10), 2965 | 10.3390/jcm13102965 |
| The Bacterial Meningitis Epidemic in Banalia in the Democratic Republic of Congo in 2021 | Bita Fouda A.A. et al. | 2024 | Vaccines 12 (5), 461 | 10.3390/vaccines12050461 |
| A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model | Brunet J. et al. | 2024 | Journal of Virology 98 (5) | 10.1128/jvi.01693-23 |
| Predicting consequences of COVID-19 control measure de-escalation on nosocomial transmission and mortality: a modelling study in a French rehabilitation hospital | Smith D.R.M. et al. | 2024 | Journal of Hospital Infection 147, pp. 47-55 | 10.1016/j.jhin.2024.02.020 |
| AI-guided pipeline for protein–protein interaction drug discovery identifies a SARS-CoV-2 inhibitor | Trepte P. et al. | 2024 | Molecular Systems Biology 20 (4), pp. 428-457 | 10.1038/s44320-024-00019-8 |
| TMPRSS2 is the receptor of seasonal coronavirus HKU1 | Saunders N. ; Schwartz O. | 2024 | Medecine/Sciences 40 (4), pp. 335-337 | 10.1051/medsci/2024034 |
| Psychotropic Medication Prescribing for Children and Adolescents After the Onset of the COVID-19 Pandemic | Valtuille Z. et al. | 2024 | JAMA network open 7 (4), pp. e247965 | 10.1001/jamanetworkopen.2024.7965 |
| Revealing the hidden interplay: The unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2, and influenza | Ghelfenstein-Ferreira T. ; Serris A. ; Salmona M. ; Lanternier F. ; Alanio A. | 2024 | Medical Mycology 62 (4), myae021 | 10.1093/mmy/myae021 |
| Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020–30: a modelling study | Hartner A.M. et al. | 2024 | The Lancet Global Health 12 (4), pp. e563-e571 | 10.1016/S2214-109X(23)00603-4 |
| Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine | Cajander S. et al. | 2024 | The Lancet Respiratory Medicine 12 (4), pp. 305-322 | 10.1016/S2213-2600(23)00330-2 |
| COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022 | Delaunay C.L. et al. | 2024 | Eurosurveillance 29 (13), 2300403 | 10.2807/1560-7917.ES.2024.29.13.2300403 |
| Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variants | Planas D. et al. | 2024 | Heliyon 10 (5), e27033 | 10.1016/j.heliyon.2024.e27033 |
| Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic | Kovacevic A. et al. | 2024 | eLife 13 | 10.7554/eLife.85701 |
| A Longitudinal Study in Tunisia to Assess the Anti-RBD IgG and IgA Responses Induced by Three Different COVID-19 Vaccine Platforms | Ben Hamouda W. et al. | 2024 | Tropical Medicine and Infectious Disease 9 (3), 61 | 10.3390/tropicalmed9030061 |
| Use of Herbal Medicine in French Guiana: Influences and Challenges for Prevention Strategies in the Context of the COVID-19 Pandemic | Forsans G. et al. | 2024 | Journal of Herbal Medicine 44, 100848 | 10.1016/j.hermed.2024.100848 |
| Comparative reconstruction of SARS-CoV-2 transmission in three African countries using a mathematical model integrating immunity data | Naffeti B. et al. | 2024 | IJID Regions 10, pp. 100-107 | 10.1016/j.ijregi.2023.11.011 |
| Drug-induced hearing loss: Listening to the latest advances | Reynard P. ; Thai-Van H. | 2024 | Therapies 79 (2), pp. 283-295 | 10.1016/j.therap.2023.10.011 |
| Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021 | Beauté J. et al. | 2024 | Eurosurveillance 29 (7) | 10.2807/1560-7917.ES.2024.29.7.2300266 |
| Increased Risk of Invasive Aspergillosis in Immunocompromised Patients With Persistent SARS-CoV-2 Viral Shedding >8 Weeks, Retrospective Case-control Study | Melenotte C. et al. | 2024 | Open Forum Infectious Diseases 11 (2), ofae012 | 10.1093/ofid/ofae012 |
| Sudden Sensorineural Hearing Loss after COVID-19 Vaccination: A Review of the Available Evidence through the Prism of Causality Assessment | Thai-Van H. ; Bagheri H. ; Valnet-Rabier M.B. | 2024 | Vaccines 12 (2), 181 | 10.3390/vaccines12020181 |
| High seroprevalence of severe acute respiratory syndrome coronavirus 2 among healthcare workers in Yaoundé, Cameroon after the first wave of Covid-19 pandemic and associated factors | Tejiokem M.C. et al. | 2024 | Influenza and other Respiratory Viruses 18 (2), e13239 | 10.1111/irv.13239 |
| SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency | Zhang L. et al. | 2024 | Cell 187 (3), pp. 596-608.e17 | 10.1016/j.cell.2023.12.025 |
| Source of SARS-CoV-2 infection: results from a series of 584,846 cases in France from October 2020 to August 2022 | Rakover A. et al. | 2024 | BMC public health 24 (1), pp. 325 | 10.1186/s12889-024-17772-y |
| Humoral immune escape by current SARS-CoV-2 variants BA.2.86 and JN.1, December 2023 | Jeworowski L.M. et al. | 2024 | Eurosurveillance 29 (2) | 10.2807/1560-7917.ES.2024.29.2.2300740 |
| Neurodevelopmental outcomes of infants after in utero exposure to SARS-CoV-2 or mRNA-COVID-19 vaccine compared with unexposed infants: a COVI-PREG prospective cohort study | Favre G. et al. | 2024 | Clinical Microbiology and Infection | 10.1016/j.cmi.2024.10.019 |
| A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification | Rosen L.E. et al. | 2024 | Cell | 10.1016/j.cell.2024.09.026 |
| Feasibility, Acceptability, Satisfaction, and Challenges of an mHealth App (e-ASCov) for Community-Based COVID-19 Screening by Community Health Workers in Rwanda: Mixed Methods Study | Omorou A.Y. et al. | 2024 | JMIR mHealth and uHealth 12, e50745 | 10.2196/50745 |
| Increased incidence of seronegative autoimmune hepatitis in children during SARS-CoV-2 pandemia period | Schmutz M. et al. | 2024 | Frontiers in Immunology 15, 1445610 | 10.3389/fimmu.2024.1445610 |
| High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccination | Rubio R. et al. | 2024 | Microbes and Infection , 105423 | 10.1016/j.micinf.2024.105423 |
| In Vitro and In Vivo Neutralizing Efficacy of Monoclonal Antibodies Against Sars-Cov-2 Variants in Kidney Transplant Recipients | Benotmane I. et al. | 2024 | Transplant International 37, 13272 | 10.3389/ti.2024.13272 |
| Transient reemergence of Bordetella parapertussis in France in 2022 | Bouchez V. et al. | 2024 | Journal of Medical Microbiology 73 (7), 001843 | 10.1099/jmm.0.001843 |
| COVID-19 Vaccine Effectiveness in Autumn and Winter 2022 to 2023 among Older Europeans | Laniece Delaunay C. et al. | 2024 | JAMA Network Open , pp. e2419258 | 10.1001/jamanetworkopen.2024.19258 |
| Implications of O-glycan modifications in the hinge region of a plant-produced SARS-CoV-2-IgA antibody on functionality | Uetz P. et al. | 2024 | Frontiers in Bioengineering and Biotechnology 12, 1329018 | 10.3389/fbioe.2024.1329018 |
| Neutralizing and enhancing monoclonal antibodies in SARS-CoV-2 convalescent patients: lessons from early variant infection and impact on shaping emerging variants | Coutant F. et al. | 2024 | Emerging Microbes and Infections 13 (1), 2307510 | 10.1080/22221751.2024.2307510 |
| Viral Zoonoses: Interactions and Factors Driving Virus Transmission | Ermonval M. ; Morand S. | 2024 | Viruses 16 (1), 9 | 10.3390/v16010009 |
| High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1 | Bolland W. et al. | 2024 | Journal of Virology 98 (1) | 10.1128/jvi.01351-23 |
| Coronavirus M Protein Trafficking in Epithelial Cells Utilizes a Myosin Vb Splice Variant and Rab10 | Lapierre L.A. et al. | 2024 | Cells 13 (2), 126 | 10.3390/cells13020126 |
| The Nairobi Declaration 2023: A commitment to address deadly yet neglected fungal diseases in Africa | Osaigbovo I.I. et al. | 2024 | Medical Mycology 62 (1), myad141 | 10.1093/mmy/myad141 |
| A short sequence in the tail of SARS-CoV-2 envelope protein controls accessibility of its PDZ-binding motif to the cytoplasm | Neitthoffer B. et al. | 2024 | Journal of Biological Chemistry 300 (1), 105575 | 10.1016/j.jbc.2023.105575 |
| Risk Factors for Community and Intrahousehold Transmission of SARS-CoV-2: Modeling in a Nationwide French Population-Based Cohort Study, the EpiCoV Study | Novelli S. et al. | 2024 | American Journal of Epidemiology 193 (1), pp. 134-148 | 10.1093/aje/kwad174 |
| Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children | Bastard P. et al. | 2024 | Journal of Experimental Medicine 221 (2), e20231353 | 10.1084/jem.20231353 |
| Vaccine-preventable Pediatric Acute Bacterial Meningitis in France: A Time Series Analysis of a 19-Year Prospective National Surveillance Network | Rybak A. et al. | 2024 | Pediatric Infectious Disease Journal 43 (1), pp. 74-83 | 10.1097/INF.0000000000004134 |
| Neutralizing Antibody Levels as a Correlate of Protection Against SARS-CoV-2 Infection: A Modeling Analysis | Lingas G. et al. | 2024 | Clinical Pharmacology and Therapeutics 115 (1), pp. 86-94 | 10.1002/cpt.3069 |
| Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs | Bastard P. et al. | 2023 | Science Immunology 8 (90), eabp8966 | 10.1126/sciimmunol.abp8966 |
| An ACE2-Based Bimodular Fusion Protein Enables Reorientation of Endogenous Anti–Epstein-Barr Virus Antibodies Toward SARS-CoV-2 Spike | Chêne A. et al. | 2023 | Journal of Infectious Diseases 228 (12), pp. 1675-1679 | 10.1093/infdis/jiad329 |
| Transcriptomic analysis of sorted lung cells revealed a proviral activity of the NF-κB pathway toward SARS-CoV-2 | Bhargava A. et al. | 2023 | iScience 26 (12), 108449 | 10.1016/j.isci.2023.108449 |
| TMPRSS2 is a functional receptor for human coronavirus HKU1 | Saunders N. et al. | 2023 | Nature 624 (7990), pp. 207-214 | 10.1038/s41586-023-06761-7 |
| Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial | Leblanc J. et al. | 2023 | PLoS Medicine 20 (12), e1004317 | 10.1371/journal.pmed.1004317 |
| Author Correction: Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants (Nature Communications, (2023), 10.1038/s41467-023-40228-7) | de Melo G.D. et al. | 2023 | Nature Communications 14 (1), 8024 | 10.1038/s41467-023-42800-7 |
| Virus isolation and neutralisation of SARS-CoV-2 variants BA.2.86 and EG.5.1 | Lassaunière R. et al. | 2023 | The Lancet Infectious Diseases 23 (12), pp. e509-e510 | 10.1016/S1473-3099(23)00682-5 |
| Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France | Oudin Doglioni D. et al. | 2023 | Scientific Reports 13 (1), 19895 | 10.1038/s41598-023-46864-9 |
| Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study | Tan-Lhernould L. et al. | 2023 | BMC Medicine 21 (1), 426 | 10.1186/s12916-023-03119-8 |
| SARS-CoV-2 viral persistence in lung alveolar macrophages is controlled by IFN-γ and NK cells | Huot N. et al. | 2023 | Nature Immunology 24 (12), pp. 2068-2079 | 10.1038/s41590-023-01661-4 |
| Impact of influenza immunity on the mortality among older adults hospitalized with COVID-19: a retrospective cohort study | Coulongeat M. et al. | 2023 | Clinical and Experimental Medicine 23 (8), pp. 4955-4965 | 10.1007/s10238-023-01203-0 |
| The rapid rebound of invasive meningococcal disease in France at the end of 2022 | Taha S. et al. | 2023 | Journal of Infection and Public Health 16 (12), pp. 1954-1960 | 10.1016/j.jiph.2023.10.001 |
| Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets | Haas K.M. et al. | 2023 | Nature Communications 14 (1), 6030 | 10.1038/s41467-023-41442-z |
| An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern | Perez-Romero C.A. et al. | 2023 | Scientific Reports 13 (1), 15782 | 10.1038/s41598-023-42348-y |
| Increased Incidence of Pediatric Uveitis Associated with the COVID-19 Pandemic Occurring Before COVID-19 Vaccine Implementation: A Time-Series Analysis | Lafay C. et al. | 2023 | Journal of Pediatrics 263, 113682 | 10.1016/j.jpeds.2023.113682 |
| Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study | Contejean A. et al. | 2023 | American Journal of Hematology 98 (12), pp. E349-E353 | 10.1002/ajh.27071 |
| A conformational rearrangement of the SARS-CoV-2 host protein sigma-1 is required for antiviral activity: insights from a combined in-silico/in-vitro approach | Abatematteo F.S. et al. | 2023 | Scientific Reports 13 (1), 12798 | 10.1038/s41598-023-39662-w |
| Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants | de Melo G.D. et al. | 2023 | Nature Communications 14 (1), 4485 | 10.1038/s41467-023-40228-7 |
| Longitudinal social contact data analysis: insights from 2 years of data collection in Belgium during the COVID-19 pandemic | Loedy N. et al. | 2023 | BMC Public Health 23 (1), 1298 | 10.1186/s12889-023-16193-7 |
| Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation: results from a case–control study | Galmiche S. et al. | 2023 | BMC Public Health 23 (1), 1240 | 10.1186/s12889-023-16144-2 |
| Impact of non-pharmaceutical interventions, weather, vaccination, and variants on COVID-19 transmission across departments in France | Paireau J. et al. | 2023 | BMC Infectious Diseases 23 (1), 190 | 10.1186/s12879-023-08106-1 |
| Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies | Planas D. et al. | 2023 | Nature Communications 14 (1), 824 | 10.1038/s41467-023-36561-6 |
| Emotional and behavioral changes in French children during the COVID-19 pandemic: a retrospective study | Landman B. et al. | 2023 | Scientific Reports 13 (1), 2003 | 10.1038/s41598-023-29193-9 |
| Modeling the impact of national and regional lockdowns on the 2020 spring wave of COVID-19 in France | Roux J. ; Massonnaud C.R. ; Colizza V. ; Cauchemez S. ; Crépey P. | 2023 | Scientific Reports 13 (1), 1834 | 10.1038/s41598-023-28687-w |
| Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency | Le Voyer T. et al. | 2023 | Nature 623 (7988), pp. 803-813 | 10.1038/s41586-023-06717-x |
| Fast and Accurate Maximum‑Likelihood Estimation of Multi‑Type Birth–Death Epidemiological Models from Phylogenetic Trees | Zhukova A. ; Hecht F. ; Maday Y. ; Gascuel O. | 2023 | Systematic Biology 72 (6), pp. 1387-1402 | 10.1093/sysbio/syad059 |
| Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022 | Meslé M.M.I. et al. | 2023 | Influenza and other Respiratory Viruses 17 (11), e13219 | 10.1111/irv.13219 |
| The Wood equation allows consistent fitting of individual antibody-response profiles of Zika virus or SARS-CoV-2 infected patients | Denis J. et al. | 2023 | Heliyon 9 (11), e21945 | 10.1016/j.heliyon.2023.e21945 |
| How have mathematical models contributed to understanding the transmission and control of SARS-CoV-2 in healthcare settings? A systematic search and review | Smith D.R.M. et al. | 2023 | Journal of Hospital Infection 141, pp. 132-141 | 10.1016/j.jhin.2023.07.028 |
| A synthetic delivery vector for mucosal vaccination | Billet A. et al. | 2023 | Biomaterials 302, 122298 | 10.1016/j.biomaterials.2023.122298 |
| Synthesis and Evaluation of 9-Aminoacridines with SARS-CoV-2 Antiviral Activity | Jones T. et al. | 2023 | ACS Omega 8 (43), pp. 40817-40822 | 10.1021/acsomega.3c05900 |
| Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patients | Bruel T. et al. | 2023 | Med 4 (10), pp. 664-667 | 10.1016/j.medj.2023.07.007 |
| SARS-CoV-2 variants of concern in children and adolescents with COVID-19: a systematic review | Wiedenmann M. et al. | 2023 | BMJ Open 13 (10), e072280 | 10.1136/bmjopen-2023-072280 |
| A rapid qualitative methods assessment and reporting tool for epidemic response as the outcome of a rapid review and expert consultation | Dong D. et al. | 2023 | PLOS Global Public Health 3 (10 October), e0002320 | 10.1371/journal.pgph.0002320 |
| SARS-CoV-2 replicates in the human testis with slow kinetics and has no major deleterious effects ex vivo | Mahé D. et al. | 2023 | Journal of Virology 97 (10) | 10.1128/jvi.01104-23 |
| Monitoring the reproductive number of COVID-19 in France: Comparative estimates from three datasets | Bonaldi C. ; Fouillet A. ; Sommen C. ; Lévy-Bruhl D. ; Paireau J. | 2023 | PLoS ONE 18 (10 October), e0293585 | 10.1371/journal.pone.0293585 |
| Neuroimmunology of rabies: New insights into an ancient disease | Bastos V. et al. | 2023 | Journal of Medical Virology 95 (10), e29042 | 10.1002/jmv.29042 |
| Neutralization, effector function and immune imprinting of Omicron variants | Addetia A. et al. | 2023 | Nature 621 (7979), pp. 592-601 | 10.1038/s41586-023-06487-6 |
| Risk of SARS-CoV-2 Infection among Households with Children in France, 2020-2022 | Galmiche S. et al. | 2023 | JAMA Network Open 6 (9), pp. E2334084 | 10.1001/jamanetworkopen.2023.34084 |
| SARS-CoV-2 Omicron BA.1 breakthrough infection drives late remodeling of the memory B cell repertoire in vaccinated individuals | Sokal A. et al. | 2023 | Immunity 56 (9), pp. 2137-2151.e7 | 10.1016/j.immuni.2023.07.007 |
| A second update on mapping the human genetic architecture of COVID-19 | Kanai M. et al. | 2023 | Nature 621 (7977), pp. E7-E26 | 10.1038/s41586-023-06355-3 |
| Dissecting human population variation in single-cell responses to SARS-CoV-2 | Aquino Y. et al. | 2023 | Nature 621 (7977), pp. 120-128 | 10.1038/s41586-023-06422-9 |
| Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication | Le Chevalier F. et al. | 2023 | Microbes and Infection 25 (7), 105142 | 10.1016/j.micinf.2023.105142 |
| The Many Hosts of Mycobacteria 9 (MHM9): A conference report | Klever A.M. et al. | 2023 | Tuberculosis 142, 102377 | 10.1016/j.tube.2023.102377 |
| Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium | Shaw D. et al. | 2023 | The Lancet Digital Health 5 (9), pp. e582-e593 | 10.1016/S2589-7500(23)00108-5 |
| Evaluating the strategies to control SARS-CoV-2 Delta variant spread in New Caledonia, a zero-COVID country until September 2021 | Ochida N. et al. | 2023 | IJID Regions 8, pp. 64-70 | 10.1016/j.ijregi.2023.06.004 |
| Lessons from COVID-19 for rescalable data collection | Bhatia S. et al. | 2023 | The Lancet Infectious Diseases 23 (9), pp. e383-e388 | 10.1016/S1473-3099(23)00121-4 |
| Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults | Araujo-Chaveron L. et al. | 2023 | Vaccine 41 (37), pp. 5412-5423 | 10.1016/j.vaccine.2023.07.002 |
| RESEARCH ARTICLE Investigations into SARS-CoV-2 and other coronaviruses on mink farms in France late in the first year of the COVID-19 pandemic | Wasniewski M. et al. | 2023 | PLoS ONE 18 (8 August), e0290444 | 10.1371/journal.pone.0290444 |
| Impact of variants of concern on SARS-CoV-2 viral dynamics in non-human primates | Marc A. et al. | 2023 | PLoS Computational Biology 19 (8 August), e1010721 | 10.1371/journal.pcbi.1010721 |
| Modeling the kinetics of the neutralizing antibody response against SARS-CoV-2 variants after several administrations of Bnt162b2 | Clairon Q. et al. | 2023 | PLoS Computational Biology 19 (8 August), e1011282 | 10.1371/journal.pcbi.1011282 |
| During Sepsis and COVID-19, the Pro-Inflammatory and Anti-Inflammatory Responses Are Concomitant | Cavaillon J.M. | 2023 | Clinical Reviews in Allergy and Immunology 65 (2), pp. 183-187 | 10.1007/s12016-023-08965-1 |
| JAK Inhibition in Aicardi-Goutières Syndrome: a Monocentric Multidisciplinary Real-World Approach Study | Frémond M.L. et al. | 2023 | Journal of Clinical Immunology 43 (6), pp. 1436-1447 | 10.1007/s10875-023-01500-z |
| Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1 | Tsui J.L.H. et al. | 2023 | Science 381 (6655), pp. 336-343 | 10.1126/science.adg6605 |
| Qualitative monitoring of SARS-CoV-2 mRNA vaccination in humans using droplet microfluidics | Broketa M. et al. | 2023 | JCI Insight 8 (13), e166602 | 10.1172/JCI.INSIGHT.166602 |
| Animal Toxins: A Historical Outlook at the Institut Pasteur of Paris | Popoff M.R. ; Faure G. ; Legout S. ; Ladant D. | 2023 | Toxins 15 (7), 462 | 10.3390/toxins15070462 |
| Calculating the fraction of Kawasaki disease potentially attributable to seasonal pathogens: a time series analysis | Valtuille Z. et al. | 2023 | eClinicalMedicine 61, 102078 | 10.1016/j.eclinm.2023.102078 |
| Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome | Schön M. et al. | 2023 | European Journal of Medical Genetics 66 (7), 104754 | 10.1016/j.ejmg.2023.104754 |
| Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021 | Woudenberg T. et al. | 2023 | Eurosurveillance 28 (25), A4 | 10.2807/1560-7917.ES.2023.28.25.2200681 |
| Analyzing the Geometry and Dynamics of Viral Structures: A Review of Computational Approaches Based on Alpha Shape Theory, Normal Mode Analysis, and Poisson–Boltzmann Theories | Hsieh Y.C. ; Delarue M. ; Orland H. ; Koehl P. | 2023 | Viruses 15 (6), 1366 | 10.3390/v15061366 |
| SARS-CoV-2 E and 3a Proteins Are Inducers of Pannexin Currents | Oliveira-Mendes B.B.R. et al. | 2023 | Cells 12 (11), 1474 | 10.3390/cells12111474 |
| Collateral impacts of pandemic COVID-19 drive the nosocomial spread of antibiotic resistance: A modelling study | Smith D.R.M. ; Shirreff G. ; Temime L. ; Opatowski L. | 2023 | PLoS Medicine 20 (6 June), e1004240 | 10.1371/journal.pmed.1004240 |
| Emergence, spread and characterisation of the SARSCoV- 2 variant B.1.640 circulating in France, October 2021 to February 2022 | Picard G. et al. | 2023 | Eurosurveillance 28 (22) | 10.2807/1560-7917.ES.2023.28.22.2200671 |
| Sotrovimab retains activity against SARS-CoV-2 omicron variant BQ.1.1 in a non-human primate model | Hérate C. et al. | 2023 | Heliyon 9 (6), e16664 | 10.1016/j.heliyon.2023.e16664 |
| Severe Bacterial Infection Initially Misdiagnosed as MIS-C: Caution Needed | Stanzelova A. et al. | 2023 | Pediatric Infectious Disease Journal 42 (6), pp. E201-E203 | 10.1097/INF.0000000000003896 |
| SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances of infection in France: a case series analysis from the ComCor study | Galmiche S. et al. | 2023 | The Lancet Microbe 4 (6), pp. e409-e417 | 10.1016/S2666-5247(23)00005-8 |
| Emergence and evolution of the Omicron SARS-CoV-2 variant in the island of Martinique | Gbaguidi G.N. et al. | 2023 | Infectious Diseases Now 53 (4), 104690 | 10.1016/j.idnow.2023.104690 |
| Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children | Avramescu M. et al. | 2023 | Kidney International 103 (6), pp. 1193-1198 | 10.1016/j.kint.2023.02.028 |
| Reply to: The role of pets in SARS-CoV-2 transmission: an exploratory analysis | Galmiche S. ; Charmet T. ; Mailles A. ; Fontanet A. | 2023 | Infection 51 (3), pp. 793-795 | 10.1007/s15010-022-01951-3 |
| Community engagement: learning from low-income countries | Kutalek R. ; Ahmed S.M. ; Kaawa-Mafigiri D. ; Giles-Vernick T. | 2023 | The Lancet 401 (10390), pp. 1767-1768 | 10.1016/S0140-6736(23)00568-8 |
| Highlights from the Inaugural HIV Reservoirs and Immune Control Conference, October 1st–4th 2023, Malahide Ireland | O’Doherty U. ; Martinez-Picado J. ; Sáez-Cirión A. | 2023 | Pathogens and Immunity 8 (1), pp. 161-169 | 10.20411/pai.v8i1.653 |
| SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA.1 and BA.2 waves in France, January to May 2022 | Supplisson O. et al. | 2023 | Eurosurveillance 28 (18) | 10.2807/1560-7917.ES.2023.28.18.2200781 |
| Humans with inherited MyD88 and IRAK-4 deficiencies are predisposed to hypoxemic COVID-19 pneumonia | García-García A. et al. | 2023 | Journal of Experimental Medicine 220 (5), e20220170 | 10.1084/jem.20220170 |
| Sick leave due to COVID-19 during the first pandemic wave in France, 2020 | Smith D.R.M. et al. | 2023 | Occupational and Environmental Medicine 80 (5), pp. 268-272 | 10.1136/oemed-2022-108451 |
| Characteristics associated with poor COVID-19 outcomes in people with psoriasis, psoriatic arthritis and axial spondyloarthritis: Data from the COVID-19 PsoProtect and Global Rheumatology Alliance physician-reported registries | Machado P.M. et al. | 2023 | Annals of the Rheumatic Diseases 82 (5), pp. 698-709 | 10.1136/ard-2022-223499 |
| A multi-country phase 2 study to evaluate the suitcase lab for rapid detection of SARS-CoV-2 in seven Sub-Saharan African countries: Lessons from the field | Ceruti A. et al. | 2023 | Journal of Clinical Virology 162, 105422 | 10.1016/j.jcv.2023.105422 |
| Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages | Touret F. et al. | 2023 | iScience 26 (4), 106413 | 10.1016/j.isci.2023.106413 |
| SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 2020-2021 | Gallian P. et al. | 2023 | iScience 26 (4), 106222 | 10.1016/j.isci.2023.106222 |
| SARS-CoV-2-related bat virus behavior in human-relevant models sheds light on the origin of COVID-19 | Temmam S. et al. | 2023 | EMBO Reports 24 (4), e56055 | 10.15252/embr.202256055 |
| New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic | Teirlinck A.C. et al. | 2023 | European Respiratory Journal 61 (4), 2201569 | 10.1183/13993003.01569-2022 |
| Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation | Philippe A. et al. | 2023 | Archives of Cardiovascular Diseases 116 (4), pp. 183-191 | 10.1016/j.acvd.2023.01.006 |
| Development and comparative evaluation of SARS-CoV-2 S-RBD and N based ELISA tests in various African endemic settings | Benabdessalem C. et al. | 2023 | Diagnostic Microbiology and Infectious Disease 105 (4), 115903 | 10.1016/j.diagmicrobio.2023.115903 |
| Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines | Fraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D.H. | 2023 | Trends in Molecular Medicine 29 (4), pp. 255-267 | 10.1016/j.molmed.2023.01.003 |
| How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? | Pons S. et al. | 2023 | Stem Cell Reviews and Reports 19 (3), pp. 585-600 | 10.1007/s12015-022-10477-y |
| Vaccine effectiveness and duration of protection of COVID-19 mRNA vaccines against Delta and Omicron BA.1 symptomatic and severe COVID-19 outcomes in adults aged 50 years and over in France | Tamandjou Tchuem C.R. et al. | 2023 | Vaccine 41 (13), pp. 2280-2288 | 10.1016/j.vaccine.2023.02.062 |
| Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants | Chauvin C. et al. | 2023 | iScience 26 (3), 106124 | 10.1016/j.isci.2023.106124 |
| A specific molecular signature in SARS-CoV-2–infected kidney biopsies | Isnard P. et al. | 2023 | JCI Insight 8 (5), e165192 | 10.1172/jci.insight.165192 |
| Global loss of cellular m6A RNA methylation following infection with different SARS-CoV-2 variants | Vaid R. et al. | 2023 | Genome Research 33 (3), pp. 299-313 | 10.1101/gr.276407.121 |
| Lentiviral Vectors as a Vaccine Platform against Infectious Diseases | Nemirov K. et al. | 2023 | Pharmaceutics 15 (3), 846 | 10.3390/pharmaceutics15030846 |
| On the risk of further excluding outcast patient populations in South America | Ruiz E. et al. | 2023 | Annals of Hepatology 28 (2), 100901 | 10.1016/j.aohep.2023.100901 |
| The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps | Wong A. et al. | 2023 | PLoS Pathogens 19 (3), e1011167 | 10.1371/journal.ppat.1011167 |
| Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection | Fraser R. ; Orta-Resendiz A. ; Mazein A. ; Dockrell D. ; Müller-Trutwin M. | 2023 | European Respiratory Review 32 (167), 220197 | 10.1183/16000617.0197-2022 |
| Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro | Rousseaud A. et al. | 2023 | Nitric Oxide - Biology and Chemistry 132, pp. 27-33 | 10.1016/j.niox.2023.01.004 |
| Prognosis value of pupillometry in COVID-19 patients admitted in intensive care unit | Daniel M. et al. | 2023 | Autonomic Neuroscience: Basic and Clinical 245, 103057 | 10.1016/j.autneu.2022.103057 |
| Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children | Lee D. et al. | 2023 | Science 379 (6632), eabo3627 | 10.1126/science.abo3627 |
| Drawing a pandemic vulnerabilities' map: The SoNAR-global Vulnerabilities Assessment digital and its output | Vaccaro C. et al. | 2023 | Frontiers in Sociology 8, 1127647 | 10.3389/fsoc.2023.1127647 |
| Editorial: Modulation of the adaptive immune responses and chronicity of infections with enveloped viruses | Said E.A. ; Ancuta P. ; Routy J.P. ; Vartanian J.P. ; Al-Jabri A.A. | 2023 | Frontiers in Immunology 14, 1137399 | 10.3389/fimmu.2023.1137399 |
| Managing sources of error during pandemics | Cauchemez S. ; Bosetti P. ; Cowling B.J. | 2023 | Science 379 (6631), pp. 437-439 | 10.1126/science.add3173 |
| Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria | Rosain J. et al. | 2023 | Cell 186 (3), pp. 621-645.e33 | 10.1016/j.cell.2022.12.038 |
| Renal arcuate vein thrombosis-induced acute kidney injury: a rare multiple-Hit-mediated disease | Pardinhas C. et al. | 2023 | Clinical Kidney Journal 16 (2), pp. 367-373 | 10.1093/ckj/sfac244 |
| Antiviral Activity of Micafungin and Its Derivatives against SARS-CoV-2 RNA Replication | Nakajima S. et al. | 2023 | Viruses 15 (2), 452 | 10.3390/v15020452 |
| Circovirus Hepatitis Infection in Heart-Lung Transplant Patient, France | Pérot P. et al. | 2023 | Emerging Infectious Diseases 29 (2), pp. 286-293 | 10.3201/eid2902.221468 |
| Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia | Kharroubi G. et al. | 2023 | Archives of Virology 168 (2), 69 | 10.1007/s00705-022-05636-y |
| Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment | Sicsic J. ; Blondel S. ; Chyderiotis S. ; Langot F. ; Mueller J.E. | 2023 | European Journal of Health Economics 24 (1), pp. 81-98 | 10.1007/s10198-022-01454-w |
| Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: A French multi-centered prospective observational study | Dobre D. et al. | 2023 | Psychological Medicine 53 (2), pp. 342-350 | 10.1017/S0033291721001537 |
| Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors | Hassan H. et al. | 2023 | RSC Medicinal Chemistry 14 (3), pp. 507-519 | 10.1039/d2md00149g |
| Strategic silences, eroded trust: The impact of divergent COVID-19 vaccine sentiments on healthcare workers' relations with peers and patients | Heyerdahl L.W. et al. | 2023 | Vaccine 41 (4), pp. 883-891 | 10.1016/j.vaccine.2022.10.048 |
| Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination | Sokal A. et al. | 2023 | Journal of Experimental Medicine 220 (1), e20220258 | 10.1084/jem.20220258 |
| Messenger RNA (mRNA) vaccination, model of transition from basic biology to medicine | Sansonetti P.J. | 2023 | Comptes Rendus - Biologies 346, pp. 69-74 | 10.5802/crbiol.129 |
| African countries from the Pasteur Network reexamine their syndromic sentinel surveillance system associated with household contact within the AFROSCREEN program | Tejiokem M.C. et al. | 2023 | Frontiers in Public Health 11, 1292435 | 10.3389/fpubh.2023.1292435 |
| Epigenetic and gene regulatory functions of small RNAs | Cecere G. | 2023 | Comptes Rendus - Biologies 346 | 10.5802/crbiol.131 |
| Umbrella Data Management Plans to Integrate FAIR Data : Lessons From the ISIDORe and BY-COVID Consortia for Pandemic Preparedness | David R. et al. | 2023 | Data Science Journal 22, 35 | 10.5334/dsj-2023-035 |
| Development of iminosugar-based glycosidase inhibitors as drug candidates for SARS-CoV-2 virus via molecular modelling and in vitro studies | Ferjancic Z. et al. | 2023 | Journal of Enzyme Inhibition and Medicinal Chemistry 39 (1), 2289007 | 10.1080/14756366.2023.2289007 |
| Application of Machine Learning Prediction of Individual SARS-CoV-2 Vaccination and Infection Status to the French Serosurveillance Survey From March 2020 to 2022: Cross-Sectional Study | Bougeard S. et al. | 2023 | JMIR Public Health and Surveillance 9 (1), e46898 | 10.2196/46898 |
| SARS-CoV-2 hijacks neutralizing dimeric IgA for nasal infection and injury in Syrian hamsters1 | Zhou B. et al. | 2023 | Emerging Microbes and Infections 12 (2), 2245921 | 10.1080/22221751.2023.2245921 |
| Parallel vaccine discourses in Guinea: ‘grounding’ social listening for a non-hegemonic global health | Heyerdahl L.W. et al. | 2023 | Critical Public Health 33 (5), pp. 579-593 | 10.1080/09581596.2023.2245964 |
| More than one crisis: COVID-19 response actors navigating multi-dimensional crises in Flanders, Belgium | Kattumana T. et al. | 2023 | Critical Public Health 33 (5), pp. 566-578 | 10.1080/09581596.2023.2240480 |
| Divergent adaptive immune responses define two types of long COVID | Kervevan J. et al. | 2023 | Frontiers in Immunology 14, 1221961 | 10.3389/fimmu.2023.1221961 |
| Reconstructing household transmission dynamics to estimate the infectiousness of asymptomatic influenza virus infections | Tsang T.K. et al. | 2023 | Proceedings of the National Academy of Sciences of the United States of America 120 (33), e2304750120 | 10.1073/pnas.2304750120 |
| Safety Signal Generation for Sudden Sensorineural Hearing Loss Following Messenger RNA COVID-19 Vaccination:Postmarketing Surveillance Using the French Pharmacovigilance Spontaneous Reporting Database | Thai-Van H. et al. | 2023 | JMIR Public Health and Surveillance 9, e45263 | 10.2196/45263 |
| One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance | Boukli N. et al. | 2023 | Frontiers in Medicine 10, 1161268 | 10.3389/fmed.2023.1161268 |
| Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants (Frontiers in Immunology, (2021), 12, (761250), 10.3389/fimmu.2021.761250) | Vanhove B. et al. | 2023 | Frontiers in Immunology 14, 1208705 | 10.3389/fimmu.2023.1208705 |
| Genomic epidemiology of SARS-CoV-2 in Cambodia, January 2020 to February 2021 | Su Y.C.F. et al. | 2023 | Virus Evolution 9 (1), veac121 | 10.1093/ve/veac121 |
| Impact and mitigation of sampling bias to determine viral spread: Evaluating discrete phylogeography through CTMC modeling and structured coalescent model approximations | Layan M. et al. | 2023 | Virus Evolution 9 (1), vead010 | 10.1093/ve/vead010 |
| Long-term systemic and mucosal SARS-CoV-2 IgA response and its association with persistent smell and taste disorders | Denis J. et al. | 2023 | Frontiers in Immunology 14, 1140714 | 10.3389/fimmu.2023.1140714 |
| About Morgan Jouvenet's article: "Science and society in the time of the COVID-19 pandemic: Research on the natural origins of SARS-CoV-2" | Bontems F. | 2023 | Natures Sciences Societes 365 (6455) | 10.1051/nss/2023002 |
| Embracing context: Lessons from designing a dialogue-based intervention to address vaccine hesitancy | Nguyen T.T. et al. | 2023 | Frontiers in Public Health 11, 1069199 | 10.3389/fpubh.2023.1069199 |
| Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement? | Boluda S. et al. | 2023 | Free Neuropathology 4, 1 | 10.17879/freeneuropathology-2023-4584 |
| New RT-PCR Assay for the Detection of Current and Future SARS-CoV-2 Variants | Marchini A. et al. | 2023 | Viruses 15 (1), 206 | 10.3390/v15010206 |
| Full-Lung Prophylaxis against SARS-CoV-2 by One-Shot or Booster Intranasal Lentiviral Vaccination in Syrian Golden Hamsters | Vesin B. et al. | 2023 | Vaccines 11 (1), 12 | 10.3390/vaccines11010012 |
| Main modulators of COVID-19 epidemic in sub-Saharan Africa | Zinsou B.E. et al. | 2023 | Heliyon 9 (1), e12727 | 10.1016/j.heliyon.2022.e12727 |
| Antibodies as drugs—a Keystone Symposia report | Cable J. et al. | 2023 | Annals of the New York Academy of Sciences 1519 (1), pp. 153-166 | 10.1111/nyas.14915 |
| Should We Interfere with the Interleukin-6 Receptor During COVID-19: What Do We Know So Far? | Plocque A. et al. | 2023 | Drugs 83 (1), pp. 1-36 | 10.1007/s40265-022-01803-2 |
| Effect of the COVID-19 pandemic on emergency gastrointestinal surgery in a university hospital in Paris over three consecutive years: A cohort study | Paktoris H. ; Montravers P. ; Rebibo L. ; Ribeiro L. ; Gouel-Chéron A. | 2023 | European Journal of Anaesthesiology 40 (1), pp. 60-63 | 10.1097/EJA.0000000000001737 |
| Modelling the end of a Zero-COVID strategy using nirmatrelvir/ritonavir, vaccination and NPIs in Wallis and Futuna | Brault A. et al. | 2023 | The Lancet Regional Health - Western Pacific 30, 100634 | 10.1016/j.lanwpc.2022.100634 |
| Statistical Analysis of Post-Translational Modifications Quantified by Label-Free Proteomics Across Multiple Biological Conditions with R: Illustration from SARS-CoV-2 Infected Cells | Giai Gianetto Q. | 2023 | Methods in Molecular Biology 2426, pp. 267-302 | 10.1007/978-1-0716-1967-4_12 |
| A proteome-scale map of the SARS-CoV-2–human contactome | Kim D.K. et al. | 2023 | Nature Biotechnology 41 (1), pp. 140-149 | 10.1038/s41587-022-01475-z |
| The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule | Colson P. et al. | 2023 | Journal of Medical Virology 95 (1), e28102 | 10.1002/jmv.28102 |
| Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies | Bruel T. et al. | 2022 | Cell Reports Medicine 3 (12), 100850 | 10.1016/j.xcrm.2022.100850 |
| Louis Pasteur, COVID-19, and the social challenges of epidemics | Giles-Vernick T. ; Cheah P.Y. ; Matta G. ; Lima N.T. | 2022 | The Lancet 400 (10369), pp. 2166-2168 | 10.1016/S0140-6736(22)02488-6 |
| Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infection | Planas D. et al. | 2022 | Med 3 (12), pp. 838-847.e3 | 10.1016/j.medj.2022.09.010 |
| IMPACTS OF THE COVID-19 PANDEMIC ON CHILDREN AND ADOLESCENTS | Trebossen V. ; Khoury É. ; Delorme R. | 2022 | Revue du Praticien 72 (10), pp. 1067-1070 | |
| Viruses to rescue health: Vaccination | Tangy F. ; Tournier J.N. | 2022 | Medecine/Sciences 38 (12), pp. 1052-1060 | 10.1051/medsci/2022168 |
| Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years | Durier C. et al. | 2022 | Scientific Reports 12 (1), 20373 | 10.1038/s41598-022-24409-w |
| Defective activation and regulation of type I interferon immunity is associated with increasing COVID-19 severity | Smith N. et al. | 2022 | Nature Communications 13 (1), 7254 | 10.1038/s41467-022-34895-1 |
| Estimating the risk of incident SARS-CoV-2 infection among healthcare workers in quarantine hospitals: the Egyptian example | Jijón S. et al. | 2022 | Scientific Reports 12 (1), 19773 | 10.1038/s41598-022-23428-x |
| MEPSi: A tool for simulating tomograms of membrane-embedded proteins | Rodríguez de Francisco B. ; Bezault A. ; Xu X.P. ; Hanein D. ; Volkmann N. | 2022 | Journal of Structural Biology 214 (4), 107921 | 10.1016/j.jsb.2022.107921 |
| Capturing SARS-CoV-2 from patient samples with low viral abundance: a comparative analysis | Pipoli da Fonseca J. et al. | 2022 | Scientific Reports 12 (1), 19274 | 10.1038/s41598-022-23422-3 |
| Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021–22: a status-based multi-variant model | Haschka T. ; Vergu E. ; Roche B. ; Poletto C. ; Opatowski L. | 2022 | BMC Infectious Diseases 22 (1), 815 | 10.1186/s12879-022-07821-5 |
| Meningococcal disease in North America: Updates from the Global Meningococcal Initiative | Asturias E.J. et al. | 2022 | Journal of Infection 85 (6), pp. 611-622 | 10.1016/j.jinf.2022.10.022 |
| Database of SARS-CoV-2 and coronaviruses kinetics relevant for assessing persistence in food processing plants | Luong N.D.M. et al. | 2022 | Scientific Data 9 (1), 654 | 10.1038/s41597-022-01763-y |
| Temporary ICUs during the COVID-19 pandemic first wave: description of the cohort at a French centre | Zappella N. et al. | 2022 | BMC Anesthesiology 22 (1), 310 | 10.1186/s12871-022-01845-9 |
| Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report | Cable J. et al. | 2022 | Annals of the New York Academy of Sciences 1518 (1), pp. 209-225 | 10.1111/nyas.14898 |
| The effect of COVID certificates on vaccine uptake, health outcomes, and the economy | Oliu-Barton M. et al. | 2022 | Nature Communications 13 (1), 3942 | 10.1038/s41467-022-31394-1 |
| Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen | Mac Kain A. et al. | 2022 | Nature Communications 13 (1), 2442 | 10.1038/s41467-022-30134-9 |
| Impact of non-pharmaceutical interventions on SARS-CoV-2 outbreaks in English care homes: a modelling study | Rosello A. et al. | 2022 | BMC Infectious Diseases 22 (1), 324 | 10.1186/s12879-022-07268-8 |
| Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19 | Faucher B. et al. | 2022 | Nature Communications 13 (1), 1414 | 10.1038/s41467-022-29015-y |
| Antibody escape and global spread of SARS-CoV-2 lineage A.27 | Kaleta T. et al. | 2022 | Nature Communications 13 (1), 1152 | 10.1038/s41467-022-28766-y |
| Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France | Bosetti P. et al. | 2022 | BMC Medicine 20 (1), 33 | 10.1186/s12916-022-02235-1 |
| Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk | Smith D.R.M. et al. | 2022 | Nature Communications 13 (1), 236 | 10.1038/s41467-021-27845-w |
| Imprinted antibody responses against SARS-CoV-2 Omicron sublineages | Park Y.J. et al. | 2022 | Science 378 (6620), pp. 619-627 | 10.1126/science.adc9127 |
| The DEAD box RNA helicase DDX42 is an intrinsic inhibitor of positive-strand RNA viruses | Bonaventure B. et al. | 2022 | EMBO Reports 23 (11), e54061 | 10.15252/embr.202154061 |
| Combined monitoring of IgG and IgA anti-Spike and anti-Receptor binding domain long term responses following BNT162b2 mRNA vaccination in Greek healthcare workers | Sarrigeorgiou I. et al. | 2022 | PLoS ONE 17 (11 November), e0277827 | 10.1371/journal.pone.0277827 |
| Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2 | Planchais C. et al. | 2022 | Protein Science 31 (11), e4447 | 10.1002/pro.4447 |
| Upward trend for “Microbes and infection” | Dussurget O. ; Ojcius D.M. | 2022 | Microbes and Infection 24 (8), 105057 | 10.1016/j.micinf.2022.105057 |
| Dynamics of SARS-CoV-2 lineages in French Guiana in 2020–2021: 4 epidemic waves with cross-influences from Europe and South America | Miliu A. et al. | 2022 | Infection, Genetics and Evolution 105, 105370 | 10.1016/j.meegid.2022.105370 |
| The mitochondrial seryl-tRNA synthetase SARS2 modifies onset in spastic paraplegia type 4 | Parodi L. et al. | 2022 | Genetics in Medicine 24 (11), pp. 2308-2317 | 10.1016/j.gim.2022.07.023 |
| SARS-CoV-2 exposures of healthcare workers from primary care, long-term care facilities and hospitals: a nationwide matched case-control study | Belan M. et al. | 2022 | Clinical Microbiology and Infection 28 (11), pp. 1471-1476 | 10.1016/j.cmi.2022.05.038 |
| The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling | Laplantine E. et al. | 2022 | iScience 25 (10), 105066 | 10.1016/j.isci.2022.105066 |
| Rapid investigation of BA.4/BA.5 cases in France | Kouamen A.C. et al. | 2022 | Frontiers in Public Health 10, 1006631 | 10.3389/fpubh.2022.1006631 |
| The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance | Tegally H. et al. | 2022 | Science 378 (6615), eabq5358 | 10.1126/science.abq5358 |
| The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants | Gellenoncourt S. et al. | 2022 | Journal of Virology 96 (19) | 10.1128/jvi.01301-22 |
| No durable impact of COVID-19 measures on the hospital burden of respiratory syncytial virus (France, 2018–2022) | Fourgeaud J. et al. | 2022 | Journal of Infection 85 (4), pp. 436-480 | 10.1016/j.jinf.2022.06.019 |
| Saliva for molecular detection of SARS-CoV-2 in pre-school and school-age children | Delaunay-Moisan A. et al. | 2022 | Environmental Microbiology 24 (10), pp. 4725-4737 | 10.1111/1462-2920.16151 |
| An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa | Vesin B. et al. | 2022 | Molecular Therapy 30 (9), pp. 2984-2997 | 10.1016/j.ymthe.2022.04.016 |
| Human Claudin-Derived Peptides Block the Membrane Fusion Process of Zika Virus and Are Broad Flavivirus Inhibitors | Zoladek J. et al. | 2022 | Microbiology Spectrum 10 (5) | 10.1128/spectrum.02989-22 |
| Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control | Mura M. ; Simon F. ; Pommier de Santi V. ; Tangy F. ; Tournier J.N. | 2022 | Vaccines 10 (9), 1555 | 10.3390/vaccines10091555 |
| Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study | Bruel T. et al. | 2022 | eClinicalMedicine 51, 101576 | 10.1016/j.eclinm.2022.101576 |
| Bronchiolitis epidemics in France during the SARS-CoV-2 pandemic: The 2020–2021 and 2021–2022 seasons | Vaux S. et al. | 2022 | Infectious Diseases Now 52 (6), pp. 374-378 | 10.1016/j.idnow.2022.06.003 |
| Olfactory outcomes in Zika virus-associated Guillain–Barré syndrome | Lazarini F. et al. | 2022 | European Journal of Neurology 29 (9), pp. 2823-2831 | 10.1111/ene.15444 |
| Postscript: A pandemic read on African health and environmental histories | Giles-Vernick T. | 2022 | Health and Place 77, 102846 | 10.1016/j.healthplace.2022.102846 |
| Response to: 'Correspondence on 'Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort' by Pouletty et al' by Pino et al | Ouldali N. et al. | 2022 | Annals of the Rheumatic Diseases 81 (9), e160 | 10.1136/annrheumdis-2020-218614 |
| Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates | Marlin R. et al. | 2022 | Nature communications 13 (1), pp. 5108 | 10.1038/s41467-022-32565-w |
| Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-? | Mathian A. et al. | 2022 | Annals of the Rheumatic Diseases 81 (12), pp. 1695-1703 | 10.1136/ard-2022-222549 |
| The genetic and evolutionary determinants of COVID-19 susceptibility | Kerner G. ; Quintana-Murci L. | 2022 | European Journal of Human Genetics 30 (8), pp. 915-921 | 10.1038/s41431-022-01141-7 |
| Aspergillus detection in airways of ICU COVID-19 patients: To treat or not to treat? | Bounhiol A. ; Pasquier G. ; Novara A. ; Bougnoux M.E. ; Dannaoui E. | 2022 | Journal of Medical Mycology 32 (3), 101290 | 10.1016/j.mycmed.2022.101290 |
| Severe relapse of SARS-CoV-2 infection in a kidney transplant recipient with negative nasopharyngeal SARS-CoV-2 RT-PCR after rituximab | Morel A. et al. | 2022 | American Journal of Transplantation 22 (8), pp. 2099-2103 | 10.1111/ajt.17000 |
| Author Correction: Bat coronaviruses related to SARS-CoV-2 and infectious for human cells (Nature, (2022), 604, 7905, (330-336), 10.1038/s41586-022-04532-4) | Temmam S. et al. | 2022 | Nature 607 (7920), pp. E19 | 10.1038/s41586-022-05048-7 |
| Tunneling nanotubes provide a route for SARS-CoV-2 spreading | Pepe A. ; Pietropaoli S. ; Vos M. ; Barba-Spaeth G. ; Zurzolo C. | 2022 | Science Advances 8 (29), eabo0171 | 10.1126/sciadv.abo0171 |
| C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus | Wu Y. et al. | 2022 | iScience 25 (7), 104537 | 10.1016/j.isci.2022.104537 |
| A mRNA Vaccine Encoding for a RBD 60-mer Nanoparticle Elicits Neutralizing Antibodies and Protective Immunity Against the SARS-CoV-2 Delta Variant in Transgenic K18-hACE2 Mice | Brandys P. et al. | 2022 | Frontiers in Immunology 13, 912898 | 10.3389/fimmu.2022.912898 |
| Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2 | Planchais C. et al. | 2022 | Journal of Experimental Medicine 219 (7), e20220638 | 10.1084/jem.20220638 |
| A close shave: How SARS-CoV-2 induces the loss of cilia | Fonseca B.F. ; Chakrabarti L.A. | 2022 | Journal of Cell Biology 221 (7), e202206023 | 10.1083/jcb.202206023 |
| Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells | Aicher S.M. et al. | 2022 | Journal of Virology 96 (14) | 10.1128/jvi.00608-22 |
| Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination | Garcia L. et al. | 2022 | Viruses 14 (7), 1491 | 10.3390/v14071491 |
| Immune Responses after a Third Dose of mRNA Vaccine Differ in Virus-Naive versus SARS-CoV-2– Recovered Dialysis Patients | Attias P. et al. | 2022 | Clinical Journal of the American Society of Nephrology 17 (7), pp. 1008-1016 | 10.2215/CJN.00830122 |
| Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protection | Alexandre M. et al. | 2022 | eLife 11, e75427 | 10.7554/elife.75427 |
| Measuring Basic Reproduction Number to Assess Effects of Nonpharmaceutical Interventions on Nosocomial SARS-CoV-2 Transmission | Shirreff G. ; Zahar J.R. ; Cauchemez S. ; Temime L. ; Opatowski L. | 2022 | Emerging Infectious Diseases 28 (7), pp. 1345-1354 | 10.3201/eid2807.212339 |
| Impact of BNT162b2 Vaccination and Isolation on SARS-CoV-2 Transmission in Israeli Households: An Observational Study | Layan M. et al. | 2022 | American Journal of Epidemiology 191 (7), pp. 1224-1234 | 10.1093/aje/kwac042 |
| Antiviral activity of ciclesonide acetal derivatives blocking SARS-CoV-2 RNA replication | Tsuji G. et al. | 2022 | Journal of Pharmacological Sciences 149 (3), pp. 81-84 | 10.1016/j.jphs.2022.04.001 |
| COVID-19 outbreak in vaccinated patients from a haemodialysis unit: antibody titres as a marker of protection from infection | Boudhabhay I. et al. | 2022 | Nephrology Dialysis Transplantation 37 (7), pp. 1357-1365 | 10.1093/ndt/gfac016 |
| Screening and vaccination against COVID-19 to minimise school closure: a modelling study | Colosi E. et al. | 2022 | The Lancet Infectious Diseases 22 (7), pp. 977-989 | 10.1016/S1473-3099(22)00138-4 |
| Aedes mosquitoes in the emerging threat of urban yellow fever transmission | Gabiane G. ; Yen P.S. ; Failloux A.B. | 2022 | Reviews in Medical Virology 32 (4), e2333 | 10.1002/rmv.2333 |
| Rapidly adapting primary care sentinel surveillance across seven countries in Europe for COVID-19 in the first half of 2020: Strengths, challenges, and lessons learned | Bagaria J. et al. | 2022 | Eurosurveillance 27 (26), 2100864 | 10.2807/1560-7917.ES.2022.27.26.2100864 |
| Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation | Posseme C. et al. | 2022 | Cell Reports 39 (13), 110989 | 10.1016/j.celrep.2022.110989 |
| Association between the COVID-19 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020 | Matczak S. et al. | 2022 | Eurosurveillance 27 (25), 2100933 | 10.2807/1560-7917.ES.2022.27.25.2100933 |
| Comparing the age and sex trajectories of SARS-CoV-2 morbidity and mortality with other respiratory pathogens | Metcalf C.J.E. et al. | 2022 | Royal Society Open Science 9 (6), 211498 | 10.1098/rsos.211498 |
| Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant | Sokal A. et al. | 2022 | Immunity 55 (6), pp. 1096-1104.e4 | 10.1016/j.immuni.2022.04.002 |
| Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020 | Talla C. et al. | 2022 | IJID Regions 3, pp. 117-125 | 10.1016/j.ijregi.2022.02.007 |
| Two Separate Clusters of SARS-CoV-2 Delta Variant Infections in A Group of 41 Students Travelling from India: An Illustration of the Need for Rigorous Testing and Quarantine | Van Elslande J. et al. | 2022 | Viruses 14 (6), 1198 | 10.3390/v14061198 |
| Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis | Serris A. et al. | 2022 | Frontiers in Immunology 13, 900522 | 10.3389/fimmu.2022.900522 |
| Characterization of SARS-CoV-2 Evasion: Interferon Pathway and Therapeutic Options | Znaidia M. ; Demeret C. ; van der Werf S. ; Komarova A.V. | 2022 | Viruses 14 (6), 1247 | 10.3390/v14061247 |
| Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with chronic inflammatory rheumatic diseases | Gros C. et al. | 2022 | Revue du Rhumatisme (Edition Francaise) 89 (4), pp. 405-411 | 10.1016/j.rhum.2022.04.010 |
| Public health issues and health rendezvous for migrants from conflict zones in Ukraine: A French practice guideline | Vignier N. et al. | 2022 | Infectious Diseases Now 52 (4), pp. 193-201 | 10.1016/j.idnow.2022.04.006 |
| An early warning system for emerging SARS-CoV-2 variants | Subissi L. et al. | 2022 | Nature Medicine 28 (6), pp. 1110-1115 | 10.1038/s41591-022-01836-w |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA.1 and BA.2 in patients receiving monoclonal antibodies | Bruel T. et al. | 2022 | Nature Medicine 28 (6), pp. 1297-1302 | 10.1038/s41591-022-01792-5 |
| Is SARS-CoV-2 seroconversion a risk factor for severe and acute psychiatric symptoms in children? | Ayrolles A. et al. | 2022 | Neuropsychopharmacology Reports 42 (2), pp. 218-220 | 10.1002/npr2.12236 |
| Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021 | Kissling E. et al. | 2022 | Eurosurveillance 27 (21), A1 | 10.2807/1560-7917.ES.2022.27.21.2101104 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies | Manry J. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (21), e2200413119 | 10.1073/pnas.2200413119 |
| Trends in bacterial sepsis incidence and mortality in France between 2015 and 2019 based on National Health Data System (Système National des données de Santé (SNDS)): a retrospective observational study | Pandolfi F. ; Guillemot D. ; Watier L. ; Brun-Buisson C. | 2022 | BMJ Open 12 (5), e058205 | 10.1136/bmjopen-2021-058205 |
| Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody | Torres J.L. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (20), e2120976119 | 10.1073/pnas.2120976119 |
| Rapid Generation of In-House Serological Assays Is Comparable to Commercial Kits Critical for Early Response to Pandemics: A Case With SARS-CoV-2 | Auerswald H. et al. | 2022 | Frontiers in Medicine 9, 864972 | 10.3389/fmed.2022.864972 |
| A Case Study to Dissect Immunity to SARS-CoV-2 in a Neonate Nonhuman Primate Model | Fovet C.M. et al. | 2022 | Frontiers in Immunology 13, 855230 | 10.3389/fimmu.2022.855230 |
| An ensemble model based on early predictors to forecast COVID-19 health care demand in France | Paireau J. et al. | 2022 | Proceedings of the National Academy of Sciences of the United States of America 119 (18), e2103302119 | 10.1073/pnas.2103302119 |
| Balancing the reactogenicity of the ChAdOx1 nCov-19 vaccine against COVID-19 and the urgent need of a large immunization in healthcare workers | Chouchana L. et al. | 2022 | Therapies 77 (3), pp. 371-373 | 10.1016/j.therap.2021.07.004 |
| SARS-CoV-2 Lineage A.27: New Data from African Countries and Dynamics in the Context of the COVID-19 Pandemic | Chouikha A. et al. | 2022 | Viruses 14 (5), 1007 | 10.3390/v14051007 |
| Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants | Blanquart F. ; Hozé N. ; Cowling B.J. ; Débarre F. ; Cauchemez S. | 2022 | eLife 11, e75791 | 10.7554/eLife.75791 |
| Occurrence and transmission potential of asymptomatic and presymptomatic SARSCoV-2 infections: Update of a living systematic review and meta-analysis | Buitrago-Garcia D. et al. | 2022 | PLoS Medicine 19 (5), e1003987 | 10.1371/journal.pmed.1003987 |
| What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda | Bonner K.E. et al. | 2022 | PLoS ONE 17 (5 May), e0268063 | 10.1371/journal.pone.0268063 |
| Studying severe long COVID to understand post-infectious disorders beyond COVID-19 | Brodin P. et al. | 2022 | Nature Medicine 28 (5), pp. 879-882 | 10.1038/s41591-022-01766-7 |
| Outpatient Antibiotic Prescriptions in France: Patients and Providers Characteristics and Impact of the COVID-19 Pandemic | Bara W. ; Brun-Buisson C. ; Coignard B. ; Watier L. | 2022 | Antibiotics 11 (5), 643 | 10.3390/antibiotics11050643 |
| Seroprevalence of SARS-CoV-2 IgG Antibodies and Factors Associated with SARS-CoV-2 IgG Neutralizing Activity among Primary Health Care Workers 6 Months after Vaccination Rollout in France | Decarreaux D. et al. | 2022 | Viruses 14 (5), 957 | 10.3390/v14050957 |
| A comparison of Sars-Cov-2 vaccine platforms: the CoviCompare project | Molino D. et al. | 2022 | Nature Medicine 28 (5), pp. 882-884 | 10.1038/s41591-022-01785-4 |
| Changes in Invasive Neisseria meningitidis and Haemophilus influenzae Infections in France during the COVID-19 Pandemic | Deghmane A.E. ; Taha M.K. | 2022 | Microorganisms 10 (5), 907 | 10.3390/microorganisms10050907 |
| Measuring the effects of COVID-19-related disruption on dengue transmission in southeast Asia and Latin America: a statistical modelling study | Chen Y. et al. | 2022 | The Lancet Infectious Diseases 22 (5), pp. 657-667 | 10.1016/S1473-3099(22)00025-1 |
| A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients | Benotmane I. et al. | 2022 | Kidney International 101 (5), pp. 1073-1076 | 10.1016/j.kint.2022.02.011 |
| A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2 nsp5/3CLpro inhibitors | Chen K.Y. et al. | 2022 | Antiviral Research 201, 105272 | 10.1016/j.antiviral.2022.105272 |
| Intranasal delivery of SARS-CoV-2 spike protein is sufficient to cause olfactory damage, inflammation and olfactory dysfunction in zebrafish | Kraus A. et al. | 2022 | Brain, Behavior, and Immunity 102, pp. 341-359 | 10.1016/j.bbi.2022.03.006 |
| Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell Disorders | Rossignol J. et al. | 2022 | Journal of Allergy and Clinical Immunology: In Practice 10 (5), pp. 1356-1364.e2 | 10.1016/j.jaip.2021.12.038 |
| First cases of Omicron in France are exhibiting mild symptoms, November 2021–January 2022 | Maisa A. et al. | 2022 | Infectious Diseases Now 52 (3), pp. 160-164 | 10.1016/j.idnow.2022.02.003 |
| Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases | Gros C. et al. | 2022 | Joint Bone Spine 89 (3), 105312 | 10.1016/j.jbspin.2021.105312 |
| Bat coronaviruses related to SARS-CoV-2 and infectious for human cells | Temmam S. et al. | 2022 | Nature 604 (7905), pp. 330-336 | 10.1038/s41586-022-04532-4 |
| Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020 | Debin M. et al. | 2022 | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27 (17) | 10.2807/1560-7917.ES.2022.27.17.2100515 |
| Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021 | Moirangthem S. et al. | 2022 | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 27 (17) | 10.2807/1560-7917.ES.2022.27.17.2100617 |
| COVID-19 in Tunisia (North Africa): Seroprevalence of SARS-CoV-2 in the General Population of the Capital City Tunis | Cherif I. et al. | 2022 | Diagnostics 12 (4), 971 | 10.3390/diagnostics12040971 |
| Contributions of modelling for the control of COVID-19 nosocomial transmission | Opatowski L. ; Temime L. | 2022 | Anaesthesia Critical Care and Pain Medicine 41 (2), 101054 | 10.1016/j.accpm.2022.101054 |
| Epidemic models: why and how to use them | Sofonea M.T. ; Cauchemez S. ; Boëlle P.Y. | 2022 | Anaesthesia Critical Care and Pain Medicine 41 (2), 101048 | 10.1016/j.accpm.2022.101048 |
| Towards SARS-CoV-2 serotypes? | Simon-Loriere E. ; Schwartz O. | 2022 | Nature Reviews Microbiology 20 (4), pp. 187-188 | 10.1038/s41579-022-00708-x |
| Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH | Rensen E. et al. | 2022 | Life Science Alliance 5 (4), 202101124 | 10.26508/lsa.202101124 |
| BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus | Moyon Q. et al. | 2022 | Annals of the Rheumatic Diseases 81 (4), pp. 575-583 | 10.1136/annrheumdis-2021-221097 |
| Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022 | Bastard J. et al. | 2022 | Eurosurveillance 27 (13) | 10.2807/1560-7917.ES.2022.27.13.2200247 |
| The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation | Rajah M.M. ; Bernier A. ; Buchrieser J. ; Schwartz O. | 2022 | Journal of Molecular Biology 434 (6), 167280 | 10.1016/j.jmb.2021.167280 |
| Discovery of Genes that Modulate Flavivirus Replication in an Interferon-Dependent Manner: Effectors of the anti-flavivirus response | Lesage S. et al. | 2022 | Journal of Molecular Biology 434 (6), 167277 | 10.1016/j.jmb.2021.167277 |
| Human genetic and immunological determinants of critical COVID-19 pneumonia | Zhang Q. et al. | 2022 | Nature 603 (7902), pp. 587-598 | 10.1038/s41586-022-04447-0 |
| Association between growth of the SARS-CoV-2 epidemic and increased coughing rate in cold temperatures: Surveillance in Hokkaido, Japan | Inaida S. ; Paul R. | 2022 | BMJ Open 12 (3), e051534 | 10.1136/bmjopen-2021-051534 |
| Exploring Zebrafish Larvae as a COVID-19 Model: Probable Abortive SARS-CoV-2 Replication in the Swim Bladder | Laghi V. et al. | 2022 | Frontiers in Cellular and Infection Microbiology 12, 790851 | 10.3389/fcimb.2022.790851 |
| COVID-19 vaccination, time for a second breath? | Gerke C.E. ; Pulverer B. ; Sansonetti P.J. | 2022 | EMBO Molecular Medicine 14 (3), e15810 | 10.15252/emmm.202215810 |
| SARS-CoV-2 Omicron emergence urges for reinforced One-Health surveillance | Montagutelli X. ; van der Werf S. ; Rey F.A. ; Simon-Loriere E. | 2022 | EMBO Molecular Medicine 14 (3), e15558 | 10.15252/emmm.202115558 |
| Assessment of surveillance predictors for suspected respiratory syncytial virus, influenza and Streptococcus pneumoniae infections in children aged <5 years in Madagascar | Razanajatovo N.H. et al. | 2022 | IJID Regions 2, pp. 82-89 | 10.1016/j.ijregi.2021.12.003 |
| COVID-19 and the Burden of Confinement on Women’s Health: A Comparison between France and the United States | Merchant J. ; Vidal C. | 2022 | International Journal of Feminist Approaches to Bioethics 15 (1), pp. 119-122 | 10.3138/ijfab-15.1.14 |
| Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2 | Saunders N. et al. | 2022 | eBioMedicine 77, 103934 | 10.1016/j.ebiom.2022.103934 |
| Time-dependent bias when analysing COVID-19-associated pulmonary aspergillosis – Authors' reply | Gangneux J.P. et al. | 2022 | The Lancet Respiratory Medicine 10 (3), pp. e27 | 10.1016/S2213-2600(22)00048-0 |
| sgDI-tector: Defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs | Di Gioacchino A. et al. | 2022 | RNA 28 (3), pp. 277-289 | 10.1261/rna.078969.121 |
| Combination of Mycological Criteria: a Better Surrogate to Identify COVID-19-Associated Pulmonary Aspergillosis Patients and Evaluate Prognosis? | Dellière S. et al. | 2022 | Journal of Clinical Microbiology 60 (3), e02169-21 | 10.1128/jcm.02169-21 |
| Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner | Garnier Y. et al. | 2022 | British Journal of Haematology 196 (5), pp. 1159-1169 | 10.1111/bjh.18019 |
| Prevention of SARS-CoV-2 transmission during a large, live, indoor gathering (SPRING): a non-inferiority, randomised, controlled trial | Delaugerre C. et al. | 2022 | The Lancet Infectious Diseases 22 (3), pp. 341-348 | 10.1016/S1473-3099(21)00673-3 |
| Surveillance and control of meningococcal disease in the COVID-19 era: A Global Meningococcal Initiative review | Alderson M.R. et al. | 2022 | Journal of Infection 84 (3), pp. 289-296 | 10.1016/j.jinf.2021.11.016 |
| COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review | Benhadid-Brahmi Y. et al. | 2022 | Journal of Medical Mycology 32 (1), 101231 | 10.1016/j.mycmed.2021.101231 |
| SARS-CoV-2 Induces Cytokine Responses in Human Basophils | Bonam S.R. et al. | 2022 | Frontiers in Immunology 13, 838448 | 10.3389/fimmu.2022.838448 |
| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization | Planas D. et al. | 2022 | Nature 602 (7898), pp. 671-675 | 10.1038/s41586-021-04389-z |
| Interactions of Severe Acute Respiratory Syndrome Coronavirus 2 Protein E With Cell Junctions and Polarity PSD-95/Dlg/ZO-1-Containing Proteins | Zhu Y. et al. | 2022 | Frontiers in Microbiology 13, 829094 | 10.3389/fmicb.2022.829094 |
| Case Report: Evolution of Humoral and Cellular Immunity in Two COVID-19 Breakthrough Infections After BNT162b2 Vaccine | Gallais F. et al. | 2022 | Frontiers in Immunology 13, 790212 | 10.3389/fimmu.2022.790212 |
| Conditionality of COVID-19 vaccine acceptance in European countries | Heyerdahl L.W. et al. | 2022 | Vaccine 40 (9), pp. 1191-1197 | 10.1016/j.vaccine.2022.01.054 |
| Non-pharmaceutical interventions and COVID-19 vaccination strategies in Senegal: a modelling study | Diarra M. et al. | 2022 | BMJ Global Health 7 (2), e007236 | 10.1136/bmjgh-2021-007236 |
| The Synaptic Gene Study: Design and Methodology to Identify Neurocognitive Markers in Phelan-McDermid Syndrome and NRXN1 Deletions | Cooke J. et al. | 2022 | Frontiers in Neuroscience 16, 806990 | 10.3389/fnins.2022.806990 |
| Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infection | Sulbaran G. et al. | 2022 | Cell Reports Medicine 3 (2), 100528 | 10.1016/j.xcrm.2022.100528 |
| Editorial: Balanced and Unbalanced Immune Response to Dengue Virus in Disease Protection and Pathogenesis | Cantaert T. ; Jouvenet N. ; Diehl S.A. | 2022 | Frontiers in Immunology 13, 835731 | 10.3389/fimmu.2022.835731 |
| Pre-COVID-19 Immunity to Common Cold Human Coronaviruses Induces a Recall-Type IgG Response to SARS-CoV-2 Antigens Without Cross-Neutralisation | Miyara M. et al. | 2022 | Frontiers in Immunology 13, 790334 | 10.3389/fimmu.2022.790334 |
| Early chains of transmission of COVID-19 in France, January to March 2020 | Paireau J. et al. | 2022 | Eurosurveillance 27 (6), 2001953 | 10.2807/1560-7917.ES.2022.27.6.2001953 |
| Epidemiological and clinical insights from SARS-CoV-2 RT-PCR crossing threshold values, France, January to November 2020 | Alizon S. et al. | 2022 | Eurosurveillance 27 (6), 2100406 | 10.2807/1560-7917.ES.2022.27.6.2100406 |
| Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma | Henriquez S. et al. | 2022 | Blood 139 (6), pp. 942-946 | 10.1182/blood.2021013714 |
| Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort | Vo H.T.M. et al. | 2022 | Frontiers in Immunology 13, 817905 | 10.3389/fimmu.2022.817905 |
| A virus-derived microRNA targets immune response genes during SARS-CoV-2 infection | Singh M. et al. | 2022 | EMBO Reports 23 (2), e54341 | 10.15252/embr.202154341 |
| Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication | Danion F. et al. | 2022 | Open Forum Infectious Diseases 9 (2), ofab566 | 10.1093/ofid/ofab566 |
| FluoRNT: A robust, efficient assay for the detection of neutralising antibodies against yellow fever virus 17D | Scheck M.K. et al. | 2022 | PLoS ONE 17 (2 February), e0262149 | 10.1371/journal.pone.0262149 |
| Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study | Gangneux J.P. et al. | 2022 | The Lancet Respiratory Medicine 10 (2), pp. 180-190 | 10.1016/S2213-2600(21)00442-2 |
| High negative predictive value of RT-PCR in patients with high likelihood of SARS-CoV-2 infection | Galmiche S. et al. | 2022 | Infectious Diseases Now 52 (1), pp. 52-53 | 10.1016/j.idnow.2021.11.005 |
| Severe COVID-19 is associated with hyperactivation of the alternative complement pathway | Boussier J. et al. | 2022 | Journal of Allergy and Clinical Immunology 149 (2), pp. 550-556.e2 | 10.1016/j.jaci.2021.11.004 |
| Is the Alpha Variant of SARS-CoV-2 Associated with a Higher Viral Load Than the Historical Strain in Saliva Samples in Patients with Mild to Moderate Symptoms? | Bonnet C. et al. | 2022 | Life 12 (2), 163 | 10.3390/life12020163 |
| Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France | Grant R. et al. | 2022 | The Lancet Regional Health - Europe 13, 100278 | 10.1016/j.lanepe.2021.100278 |
| Author Correction: A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection (Nature Immunology, (2022), 23, 2, (159-164), 10.1038/s41590-021-01030-z) | Andreakos E. et al. | 2022 | Nature Immunology 23 (2), pp. 341 | 10.1038/s41590-021-01096-9 |
| A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study | Fillâtre P. et al. | 2022 | Clinical Microbiology and Infection 28 (2), pp. 298.e9-298.e15 | 10.1016/j.cmi.2021.09.035 |
| A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection | Andreakos E. et al. | 2022 | Nature Immunology 23 (2), pp. 159-164 | 10.1038/s41590-021-01030-z |
| The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity | Kovacevic A. ; Eggo R.M. ; Baguelin M. ; Domenech De Cellès M. ; Opatowski L. | 2022 | Journal of Infectious Diseases 225 (2), pp. 199-207 | 10.1093/infdis/jiab459 |
| Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22 | Bosetti P. et al. | 2022 | Eurosurveillance 27 (1), 2101125 | 10.2807/1560-7917.ES.2022.27.1.2101125 |
| The Pasteurian contribution to the history of vaccines | Schwartz M. | 2022 | Comptes Rendus - Biologies 345 (3), pp. 93-107 | 10.5802/crbiol.83 |
| Incidence and prevalence of coma in the UK and the USA | Kondziella D. et al. | 2022 | Brain Communications 4 (5), fcac188 | 10.1093/braincomms/fcac188 |
| Association of Nonpharmaceutical Interventions during the COVID-19 Pandemic with Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections among Children in France | Rybak A. et al. | 2022 | JAMA Network Open , pp. E2218959 | 10.1001/jamanetworkopen.2022.18959 |
| Validation of the Performance of A1HPV6, a Triage Blood Test for the Early Diagnosis and Prognosis of SARS-CoV-2 Infection | Maisonnasse P. et al. | 2022 | Gastro Hep Advances 1 (3), pp. 393-402 | 10.1016/j.gastha.2021.12.009 |
| Immunogenicity of BNT162b2 vaccine against the Alpha and Delta variants in immunocompromised patients with systemic inflammatory diseases | Hadjadj J. et al. | 2022 | Annals of the Rheumatic Diseases 81 (5), pp. 720-728 | 10.1136/annrheumdis-2021-221508 |
| Correction to: Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection (Journal of Clinical Immunology, (2022), 42, 1, (25-27), 10.1007/s10875-021-01119-y) | Rodero M.P. et al. | 2022 | Journal of Clinical Immunology 42 (1), pp. 28 | 10.1007/s10875-021-01135-y |
| BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2 | Samelson A.J. et al. | 2022 | Nature Cell Biology 24 (1), pp. 24-34 | 10.1038/s41556-021-00821-8 |
| Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study | Launay O. et al. | 2022 | eBioMedicine 75, 103810 | 10.1016/j.ebiom.2021.103810 |
| Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission (Nature Medicine, (2021), 27, 11, (1854-1855), 10.1038/s41591-021-01545-w) | Kraemer M.U.G. et al. | 2022 | Nature Medicine 28 (1), pp. 213 | 10.1038/s41591-021-01670-6 |
| Development of a highly specific and sensitive VHH-based sandwich immunoassay for the detection of the SARS-CoV-2 nucleoprotein | Gransagne M. et al. | 2022 | Journal of Biological Chemistry 298 (1), 101290 | 10.1016/j.jbc.2021.101290 |
| Nicotinic receptors as SARS-CoV-2 spike co-receptors? | Dormoy V. et al. | 2022 | Medical Hypotheses 158, 110741 | 10.1016/j.mehy.2021.110741 |
| Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines | Oliu-Barton M. et al. | 2022 | The Lancet Global Health 10 (1), pp. e142-e147 | 10.1016/S2214-109X(21)00494-0 |
| Rethinking the Infodemic: Social Media and Offline Action in the COVID-19 Pandemic | Heyerdahl L.W. ; Lana B. ; Giles-Vernick T. | 2022 | Economics, Law, and Institutions in Asia Pacific , pp. 73-82 | 10.1007/978-981-16-5727-6_4 |
| The COVID-19 Outbreak and Public Health Issues: An Interdisciplinary Approach | Sakuntabhai A. ; Thomann B. | 2022 | Economics, Law, and Institutions in Asia Pacific , pp. 341-353 | 10.1007/978-981-16-5727-6_15 |
| Integrating Social Sciences to Mitigate Against Covid | Paul R. ; Telle O. ; Benkimoun S. | 2022 | Economics, Law, and Institutions in Asia Pacific , pp. 47-71 | 10.1007/978-981-16-5727-6_3 |
| Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection | Rodero M.P. et al. | 2022 | Journal of Clinical Immunology 42 (1), pp. 25-27 | 10.1007/s10875-021-01119-y |
| Impact of dimerization and N3 binding on molecular dynamics of SARS-CoV and SARS-CoV-2 main proteases | Tekpinar M. ; Yildirim A. | 2022 | Journal of Biomolecular Structure and Dynamics 40 (14), pp. 6243-6254 | 10.1080/07391102.2021.1880481 |
| Mathematical modelling of SARS-CoV-2 infection of human and animal host cells reveals differences in the infection rates and delays in viral particle production by infected cells | Bernhauerová V. ; Lisowski B. ; Rezelj V.V. ; Vignuzzi M. | 2021 | Journal of Theoretical Biology 531, 110895 | 10.1016/j.jtbi.2021.110895 |
| Mapping the human genetic architecture of COVID-19 | Niemi M.E.K. et al. | 2021 | Nature 600 (7889), pp. 472-477 | 10.1038/s41586-021-03767-x |
| SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation | Rajah M.M. et al. | 2021 | EMBO Journal 40 (24), e108944 | 10.15252/embj.2021108944 |
| mRNA vaccination of naive and COVID-19-recovered individuals elicits potent memory B cells that recognize SARS-CoV-2 variants | Sokal A. et al. | 2021 | Immunity 54 (12), pp. 2893-2907.e5 | 10.1016/j.immuni.2021.09.011 |
| Brain cross-protection against SARS-CoV-2 variants by a lentiviral vaccine in new transgenic mice | Ku M.W. et al. | 2021 | EMBO Molecular Medicine 13 (12), e14459 | 10.15252/emmm.202114459 |
| Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2 | De Cellès M.D. ; Casalegno J.S. ; Lina B. ; Opatowski L. | 2021 | PeerJ 9, e12566 | 10.7717/peerj.12566 |
| Lockdown impact on age-specific contact patterns and behaviours, France, April 2020 | Bosetti P. et al. | 2021 | Eurosurveillance 26 (48), 2001636 | 10.2807/1560-7917.ES.2021.26.48.2001636 |
| Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients | Crescenzo-Chaigne B. et al. | 2021 | Journal of Clinical Virology Plus 1 (4), 100041 | 10.1016/j.jcvp.2021.100041 |
| Adherence and sustainability of interventions informing optimal control against the COVID-19 pandemic | Di Domenico L. et al. | 2021 | Communications Medicine 1 (1), 57 | 10.1038/s43856-021-00057-5 |
| The Impact of the Online COVID-19 Infodemic on French Red Cross Actors' Field Engagement and Protective Behaviors: Mixed Methods Study | Heyerdahl L.W. ; Lana B. ; Giles-Vernick T. | 2021 | JMIR Infodemiology 1 (1), e27472 | 10.2196/27472 |
| Influenza viruses and coronaviruses: Knowns, unknowns, and common research challenges | Terrier O. et al. | 2021 | PLoS Pathogens 17 (12), e1010106 | 10.1371/journal.ppat.1010106 |
| An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal route | Majlessi L. ; Charneau P. | 2021 | Medecine/Sciences 37 (12), pp. 1172-1175 | 10.1051/medsci/2021173 |
| Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance based multicenter international study—the CARDOVID registry | Aeschlimann F.A. et al. | 2021 | Journal of Cardiovascular Magnetic Resonance 23 (1), 140 | 10.1186/s12968-021-00841-1 |
| Aspergillus test profiles and mortality in critically ill covid-19 patients | Ergün M. et al. | 2021 | Journal of Clinical Microbiology 59 (12), e01229-21 | 10.1128/JCM.01229-21 |
| Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2) | Weiss A. et al. | 2021 | PLoS ONE 16 (12 December), e0260958 | 10.1371/journal.pone.0260958 |
| SARS-CoV-2 transmission across age groups in France and implications for control | Tran Kiem C. et al. | 2021 | Nature Communications 12 (1), 6895 | 10.1038/s41467-021-27163-1 |
| Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department | NguyenVan J.C. et al. | 2021 | Journal of Clinical Virology 145, 105021 | 10.1016/j.jcv.2021.105021 |
| Using secondary cases to characterize the severity of an emerging or re-emerging infection | Tsang T.K. ; Wang C. ; Yang B. ; Cauchemez S. ; Cowling B.J. | 2021 | Nature Communications 12 (1), 6372 | 10.1038/s41467-021-26709-7 |
| A novel SARS-CoV-2 related coronavirus in bats from Cambodia | Delaune D. et al. | 2021 | Nature Communications 12 (1), 6563 | 10.1038/s41467-021-26809-4 |
| Clash of the titans: interferons and SARS-CoV-2 | Jouvenet N. ; Goujon C. ; Banerjee A. | 2021 | Trends in Immunology 42 (12), pp. 1069-1072 | 10.1016/j.it.2021.10.009 |
| A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters | Frantz P.N. et al. | 2021 | Nature Communications 12 (1), 6277 | 10.1038/s41467-021-26506-2 |
| Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care | LeGoff J. et al. | 2021 | Scientific Reports 11 (1), 21126 | 10.1038/s41598-021-00560-8 |
| A cross-sectional analysis of meteorological factors and SARS-CoV-2 transmission in 409 cities across 26 countries | Sera F. et al. | 2021 | Nature Communications 12 (1), 5968 | 10.1038/s41467-021-25914-8 |
| COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models | Maisonnasse P. et al. | 2021 | Nature Communications 12 (1), 6097 | 10.1038/s41467-021-26354-0 |
| Type I interferon response and vascular alteration in chilblain-like lesions during the COVID-19 outbreak* | Frumholtz L. et al. | 2021 | British Journal of Dermatology 185 (6), pp. 1176-1185 | 10.1111/bjd.20707 |
| Emergence and spread of SARS-CoV-2 lineage B.1.620 with variant of concern-like mutations and deletions | Dudas G. et al. | 2021 | Nature Communications 12 (1), 5769 | 10.1038/s41467-021-26055-8 |
| Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential | Meyer B. et al. | 2021 | Nature Communications 12 (1), 5553 | 10.1038/s41467-021-25796-w |
| Analysis of T-cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain-like lesions during the COVID-19 pandemic | Cassius C. et al. | 2021 | British Journal of Dermatology 185 (6), pp. 1242-1244 | 10.1111/bjd.20647 |
| Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques | Marlin R. et al. | 2021 | Nature Communications 12 (1), 5215 | 10.1038/s41467-021-25382-0 |
| Impact of COVID-19 social distancing on viral infection in France: A delayed outbreak of RSV | Delestrain C. et al. | 2021 | Pediatric Pulmonology 56 (12), pp. 3669-3673 | 10.1002/ppul.25644 |
| SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance | Robinot R. et al. | 2021 | Nature Communications 12 (1), 4354 | 10.1038/s41467-021-24521-x |
| Platelet activation in critically ill COVID-19 patients | Yatim N. et al. | 2021 | Annals of Intensive Care 11 (1), 113 | 10.1186/s13613-021-00899-1 |
| Whole genome sequencing and phylogenetic analysis of six SARS-CoV-2 strains isolated during COVID-19 pandemic in Tunisia, North Africa | Fares W. et al. | 2021 | BMC Genomics 22 (1), 540 | 10.1186/s12864-021-07870-1 |
| Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis | Goubet A.G. et al. | 2021 | Cell Death and Differentiation 28 (12), pp. 3297-3315 | 10.1038/s41418-021-00817-9 |
| Cold and dry winter conditions are associated with greater SARS-CoV-2 transmission at regional level in western countries during the first epidemic wave | Landier J. et al. | 2021 | Scientific Reports 11 (1), 12756 | 10.1038/s41598-021-91798-9 |
| Regulation of the acetylcholine/α7nAChR anti-inflammatory pathway in COVID-19 patients | Courties A. et al. | 2021 | Scientific Reports 11 (1), 11886 | 10.1038/s41598-021-91417-7 |
| Acceptability of a COVID-19 pre-exposure prophylaxis trial with hydroxychloroquine in French healthcare workers during the first wave of COVID-19 pandemic | Gagneux-Brunon A. et al. | 2021 | Trials 22 (1), 373 | 10.1186/s13063-021-05329-y |
| Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance | Le Vu S. et al. | 2021 | Nature Communications 12 (1), 3025 | 10.1038/s41467-021-23233-6 |
| Lessons learned from the investigation of a COVID-19 cluster in Creil, France: effectiveness of targeting symptomatic cases and conducting contact tracing around them | de Laval F. et al. | 2021 | BMC Infectious Diseases 21 (1), 457 | 10.1186/s12879-021-06166-9 |
| Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers (Nature Communications, (2021), 12, 1, (844), 10.1038/s41467-021-21111-9) | Marot S. et al. | 2021 | Nature Communications 12 (1), 2824 | 10.1038/s41467-021-23128-6 |
| Deciphering the state of immune silence in fatal COVID-19 patients | Bost P. et al. | 2021 | Nature Communications 12 (1), 1428 | 10.1038/s41467-021-21702-6 |
| Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana | Andronico A. et al. | 2021 | Nature Communications 12 (1), 1634 | 10.1038/s41467-021-21944-4 |
| Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers | Marot S. et al. | 2021 | Nature Communications 12 (1), 844 | 10.1038/s41467-021-21111-9 |
| Guidelines of the French Society of Otorhinolaryngology and Head and Neck Surgery (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemic | Bertholon P. et al. | 2021 | Annales Francaises d'Oto-Rhino-Laryngologie et de Pathologie Cervico-Faciale 138 (6), pp. 462-468 | 10.1016/j.aforl.2020.10.002 |
| Guidelines of the French Society of Otorhinolaryngology (SFORL) for teleconsultation in patients with vertigo during the COVID-19 pandemic | Bertholon P. et al. | 2021 | European Annals of Otorhinolaryngology, Head and Neck Diseases 138 (6), pp. 459-465 | 10.1016/j.anorl.2020.11.011 |
| Atypical Prolonged Viral Shedding With Intra-Host SARS-CoV-2 Evolution in a Mildly Affected Symptomatic Patient | Cunha M.d.P. et al. | 2021 | Frontiers in Medicine 8, 760170 | 10.3389/fmed.2021.760170 |
| XAV-19, a Swine Glyco-Humanized Polyclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Domain, Targets Multiple Epitopes and Broadly Neutralizes Variants | Vanhove B. et al. | 2021 | Frontiers in Immunology 12, 761250 | 10.3389/fimmu.2021.761250 |
| Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2 | Rivière F. et al. | 2021 | Respiratory Medicine and Research 80, 100862 | 10.1016/j.resmer.2021.100862 |
| MALVIRUS: an integrated application for viral variant analysis | Ciccolella S. et al. | 2021 | BMC Bioinformatics 22, 625 | 10.1186/s12859-022-04668-0 |
| Two-photon microscopy analysis reveals different pulmonary damage after infection by influenza or SARS-CoV-2 | Frédéric R. et al. | 2021 | Respiratory medicine and research 80, pp. 100862 | 10.1016/j.resmer.2021.100862 |
| Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time since Infection | Pelleau S. et al. | 2021 | Journal of Infectious Diseases 224 (9), pp. 1489-1499 | 10.1093/infdis/jiab375 |
| Seroprevalence of anti-sars-cov-2 igg at the first epidemic peak in french guiana, july 2020 | Flamand C. et al. | 2021 | PLoS Neglected Tropical Diseases 15 (11), e0009945 | 10.1371/journal.pntd.0009945 |
| Highly Sensitive Quantification of Plasma Severe Acute Respiratory Syndrome Coronavirus 2 RNA Sheds Light on its Potential Clinical Value | Veyer D. et al. | 2021 | Clinical Infectious Diseases 73 (9), pp. E2890-E2897 | 10.1093/cid/ciaa1196 |
| Pdz-containing proteins targeted by the ace2 receptor | Caillet-Saguy C. ; Wolff N. | 2021 | Viruses 13 (11), 2281 | 10.3390/v13112281 |
| Blood fibrocytes are associated with severity and prognosis in COVID-19 pneumonia | Ghanem M. et al. | 2021 | American Journal of Physiology - Lung Cellular and Molecular Physiology 321 (5), pp. L847-L858 | 10.1152/ajplung.00545.2020 |
| “We Tried to Borrow Money, but No One Helped.” Assessing the Three-Delay Model Factors Affecting the Healthcare Service Delivery among Dengue Patients during COVID-19 Surge in a Public Tertiary Hospital: A Convergent Parallel Mixed Methods Study | Ligsay A.D. et al. | 2021 | International Journal of Environmental Research and Public Health 18 (22), 11851 | 10.3390/ijerph182211851 |
| Monitoring key epidemiological parameters of SARS-CoV-2 transmission | Kraemer M.U.G. et al. | 2021 | Nature Medicine 27 (11), pp. 1854-1855 | 10.1038/s41591-021-01545-w |
| Beta SARS-CoV-2 variant and BNT162b2 vaccine effectiveness in long-term care facilities in France | Lefèvre B. et al. | 2021 | The Lancet Healthy Longevity 2 (11), pp. e685-e687 | 10.1016/S2666-7568(21)00230-0 |
| Multi-omic approach identifies a transcriptional network coupling innate immune response to proliferation in the blood of COVID-19 cancer patients | Sacconi A. et al. | 2021 | Cell Death and Disease 12 (11), 1019 | 10.1038/s41419-021-04299-y |
| Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study | Monel B. et al. | 2021 | EBioMedicine 73, 103637 | 10.1016/j.ebiom.2021.103637 |
| Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection | Smith N. et al. | 2021 | Nature Immunology 22 (11), pp. 1428-1439 | 10.1038/s41590-021-01028-7 |
| Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study | Kernéis S. et al. | 2021 | European Journal of Clinical Microbiology and Infectious Diseases 40 (11), pp. 2379-2388 | 10.1007/s10096-021-04327-x |
| Impact of public health measures on the post-COVID-19 respiratory syncytial virus epidemics in France | Fourgeaud J. et al. | 2021 | European Journal of Clinical Microbiology and Infectious Diseases 40 (11), pp. 2389-2395 | 10.1007/s10096-021-04323-1 |
| Lupus Anticoagulant Single Positivity During the Acute Phase of COVID-19 Is Not Associated With Venous Thromboembolism or In-Hospital Mortality | Gendron N. et al. | 2021 | Arthritis and Rheumatology 73 (11), pp. 1976-1985 | 10.1002/art.41777 |
| Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials | Dautzenberg B. ; Levi A. ; Adler M. ; Gaillard R. | 2021 | Respiratory Medicine and Research 80, 100844 | 10.1016/j.resmer.2021.100844 |
| Educational Setting and SARS-CoV-2 Transmission Among Children With Multisystem Inflammatory Syndrome: A French National Surveillance System | Guenver C. et al. | 2021 | Frontiers in Pediatrics 9, 745364 | 10.3389/fped.2021.745364 |
| A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa | Wilkinson E. et al. | 2021 | Science 374 (6566), pp. 423-431 | 10.1126/science.abj4336 |
| Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines | Walls A.C. et al. | 2021 | Cell 184 (21), pp. 5432-5447.e16 | 10.1016/j.cell.2021.09.015 |
| Quantifying healthcare and welfare sector workers' preferences around COVID-19 vaccination: A cross-sectional, single-profile discrete-choice experiment in France | DÍaz Luévano C. et al. | 2021 | BMJ Open 11 (10), e055148 | 10.1136/bmjopen-2021-055148 |
| Covid-19-associated pulmonary aspergillosis, fungemia, and pneumocystosis in the intensive care unit: A retrospective multicenter observational cohort during the first french pandemic wave | Bretagne S. et al. | 2021 | Microbiology Spectrum 9 (2), e01138-21 | 10.1128/Spectrum.01138-21 |
| COVID-19-related travel restrictions temporarily reduced the demand for rabies post-exposure prophylaxis in France | Parize P. et al. | 2021 | Journal of Travel Medicine 28 (7), taab127 | 10.1093/jtm/taab127 |
| COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms | Ostaszewski M. et al. | 2021 | Molecular Systems Biology 17 (10), e10387 | 10.15252/msb.202110387 |
| New insights into human immunity from ancient genomics | Kerner G. ; Patin E. ; Quintana-Murci L. | 2021 | Current Opinion in Immunology 72, pp. 116-125 | 10.1016/j.coi.2021.04.006 |
| Telemedicine in Audiology. Best practice recommendations from the French Society of Audiology (SFA) and the French Society of Otorhinolaryngology-Head and Neck Surgery (SFORL) | Thai-Van H. et al. | 2021 | European Annals of Otorhinolaryngology, Head and Neck Diseases 138 (5), pp. 363-375 | 10.1016/j.anorl.2020.10.007 |
| Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response | Roßmann L. et al. | 2021 | Proceedings of the National Academy of Sciences of the United States of America 118 (39), e2103651118 | 10.1073/PNAS.2103651118 |
| Sera Neutralizing Activities Against Severe Acute Respiratory Syndrome Coronavirus 2 and Multiple Variants 6 Months After Hospitalization for Coronavirus Disease 2019 | Betton M. et al. | 2021 | Clinical Infectious Diseases 73 (6), pp. E1337-E1344 | 10.1093/cid/ciab308 |
| Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 | Grzelak L. et al. | 2021 | Journal of Infectious Diseases 224 (6), pp. 983-988 | 10.1093/infdis/jiab127 |
| Demographic and Clinical Characteristics Associated With Severity, Clinical Outcomes, and Mortality of COVID-19 Infection in Gabon | Iroungou B.A. et al. | 2021 | JAMA Network Open 4 (9), pp. E2124190 | 10.1001/jamanetworkopen.2021.24190 |
| A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis | de Cevins C. et al. | 2021 | Med 2 (9), pp. 1072-1092.e7 | 10.1016/j.medj.2021.08.002 |
| An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates | Zabaleta N. et al. | 2021 | Cell Host and Microbe 29 (9), pp. 1437-1453.e8 | 10.1016/j.chom.2021.08.002 |
| Broad sarbecovirus neutralization by a human monoclonal antibody | Tortorici M.A. et al. | 2021 | Nature 597 (7874), pp. 103-108 | 10.1038/s41586-021-03817-4 |
| Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France | Charmet T. et al. | 2021 | The Lancet Regional Health - Europe 8, 100171 | 10.1016/j.lanepe.2021.100171 |
| A bioluminescent 3clpro activity assay to monitor sars-cov-2 replication and identify inhibitors | Mathieu C. et al. | 2021 | Viruses 13 (9), 1814 | 10.3390/v13091814 |
| Twelfth Annual ENBDC Workshop: Methods in Mammary Gland Biology and Breast Cancer | Charifou E. ; Traustadottir G.A. ; Bentires-Alj M. ; Howard B. ; Van Keymeulen A. | 2021 | Journal of Mammary Gland Biology and Neoplasia 26 (3), pp. 221-226 | 10.1007/s10911-021-09498-z |
| Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection | Gallais F. et al. | 2021 | EBioMedicine 71, 103561 | 10.1016/j.ebiom.2021.103561 |
| Managing COVID-19 importation risks in a heterogeneous world | Cauchemez S. ; Kiem C.T. | 2021 | The Lancet Public Health 6 (9), pp. e626-e627 | 10.1016/S2468-2667(21)00188-2 |
| SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution | Zahradník J. et al. | 2021 | Nature Microbiology 6 (9), pp. 1188-1198 | 10.1038/s41564-021-00954-4 |
| ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads | Marchio A. et al. | 2021 | Archives of Virology 166 (9), pp. 2529-2540 | 10.1007/s00705-021-05149-0 |
| Characteristics Associated with Olfactory and Taste Disorders in COVID-19 | Galmiche S. et al. | 2021 | Neuroepidemiology 55 (5), pp. 381-386 | 10.1159/000517066 |
| A review of significance of Aspergillus detection in airways of ICU COVID-19 patients | Pasquier G. et al. | 2021 | Mycoses 64 (9), pp. 980-988 | 10.1111/myc.13341 |
| ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2 | Van Kerkhove M.D. et al. | 2021 | Influenza and other Respiratory Viruses 15 (5), pp. 561-568 | 10.1111/irv.12870 |
| Long COVID and the brain network of Proust's madeleine: targeting the olfactory pathway | Guedj E. et al. | 2021 | Clinical Microbiology and Infection 27 (9), pp. 1196-1198 | 10.1016/j.cmi.2021.05.015 |
| Host PDZ-containing proteins targeted by SARS-CoV-2 | Caillet-Saguy C. et al. | 2021 | FEBS Journal 288 (17), pp. 5148-5162 | 10.1111/febs.15881 |
| A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1 | Parellada M. et al. | 2021 | Frontiers in Psychiatry 12, 701729 | 10.3389/fpsyt.2021.701729 |
| Masitinib is a broad coronavirus 3CL inhibitor that blocks replication of SARS-CoV-2 | Drayman N. et al. | 2021 | Science 373 (6557), pp. 931-936 | 10.1126/science.abg5827 |
| Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence | Kraemer M.U.G. et al. | 2021 | Science 373 (6557), pp. 889-895 | 10.1126/science.abj0113 |
| X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 | Asano T. et al. | 2021 | Science Immunology 6 (62), eabl4348 | 10.1126/sciimmunol.abl4348 |
| Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths | Bastard P. et al. | 2021 | Science Immunology 6 (62), eabl4340 | 10.1126/sciimmunol.abl4340 |
| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization | Planas D. et al. | 2021 | Nature 596 (7871), pp. 276-280 | 10.1038/s41586-021-03777-9 |
| Attenuation of clinical and immunological outcomes during SARS-CoV-2 infection by ivermectin | de Melo G.D. et al. | 2021 | EMBO Molecular Medicine 13 (8), e14122 | 10.15252/emmm.202114122 |
| Transmission of SARS-CoV-2 Alpha Variant (B.1.1.7) from a BNT162b2-Vaccinated Individual | Kerneís S. et al. | 2021 | Open Forum Infectious Diseases 8 (8), ofab369 | 10.1093/ofid/ofab369 |
| Mitigating COVID-19 outbreaks in workplaces and schools by hybrid telecommuting | Mauras S. et al. | 2021 | PLoS Computational Biology 17 (8), e1009264 | 10.1371/journal.pcbi.1009264 |
| Covid-19 research: Lessons from non-human primate models | Albrecht L. et al. | 2021 | Vaccines 9 (8), 886 | 10.3390/vaccines9080886 |
| Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection | Yatim N. et al. | 2021 | Science Advances 7 (34), eabg4081 | 10.1126/sciadv.abg4081 |
| Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France | Woudenberg T. et al. | 2021 | EBioMedicine 70, 103495 | 10.1016/j.ebiom.2021.103495 |
| Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study | Galmiche S. et al. | 2021 | The Lancet Regional Health - Europe 7, 100148 | 10.1016/j.lanepe.2021.100148 |
| Low seroprevalence of COVID-19 in Lao PDR, late 2020 | Virachith S. et al. | 2021 | The Lancet Regional Health - Western Pacific 13, 100197 | 10.1016/j.lanwpc.2021.100197 |
| A modelling study investigating short and medium-term challenges for COVID-19 vaccination: From prioritisation to the relaxation of measures | Tran Kiem C. et al. | 2021 | eClinicalMedicine 38, 101001 | 10.1016/j.eclinm.2021.101001 |
| Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis | Verweij P.E. et al. | 2021 | Intensive Care Medicine 47 (8), pp. 819-834 | 10.1007/s00134-021-06449-4 |
| The Nexus between Telomere Length and Lymphocyte Count in Seniors Hospitalized with COVID-19 | Benetos A. et al. | 2021 | Journals of Gerontology - Series A Biological Sciences and Medical Sciences 76 (8), pp. E97-E101 | 10.1093/gerona/glab026 |
| What chikungunya teaches us about COVID-19 | Simon F. ; Watson H. ; Meynard J.B. ; de Santi V.P. ; Tournier J.N. | 2021 | The Lancet Infectious Diseases 21 (8), pp. 1070-1071 | 10.1016/S1473-3099(21)00272-3 |
| Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? | Cohen R. et al. | 2021 | Infectious Diseases Now 51 (5), pp. 418-423 | 10.1016/j.idnow.2021.05.004 |
| Differential serological and neutralizing antibody dynamics after an infection by a single SARS-CoV-2 strain | Billon-Denis E. et al. | 2021 | Infection 49 (4), pp. 781-783 | 10.1007/s15010-020-01556-8 |
| Education and mental health: good reasons to vaccinate children | Cauchemez S. et al. | 2021 | The Lancet 398 (10298), pp. 387 | 10.1016/S0140-6736(21)01453-7 |
| Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2 | Tummino T.A. et al. | 2021 | Science 373 (6554), 6554 | 10.1126/science.abi4708 |
| SARS-CoV-2 Nsp3 unique domain SUD interacts with guanine quadruplexes and G4-ligands inhibit this interaction | Lavigne M. et al. | 2021 | Nucleic Acids Research 49 (13), pp. 7695-7712 | 10.1093/nar/gkab571 |
| Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021 | Kissling E. et al. | 2021 | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 26 (29) | 10.2807/1560-7917.ES.2021.26.29.2100670 |
| How did institut pasteur’s ngs core facility, biomics, manage the coronavirus disease 2019 crisis? | Najjar I. et al. | 2021 | Journal of Biomolecular Techniques 32 (2), pp. 50-56 | 10.7171/jbt.21-3202-004 |
| A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic | Cazelles B. et al. | 2021 | PLoS Computational Biology 17 (7), e1009211 | 10.1371/journal.pcbi.1009211 |
| Lives saved with vaccination for 10 pathogens across 112 countries in a pre-covid-19 world | Toor J. et al. | 2021 | eLife 10, e67635 | 10.7554/eLife.67635 |
| Nationwide seroprevalence of SARS-CoV-2 IgG antibodies among four groups of primary health-care workers and their household contacts 6 months after the initiation of the COVID-19 vaccination campaign in france: seroPRIM study protocol | Pouquet M. et al. | 2021 | Pathogens 10 (7), 911 | 10.3390/pathogens10070911 |
| Host-pathogen adhesion as the basis of innovative diagnostics for emerging pathogens | van Belkum A. et al. | 2021 | Diagnostics 11 (7), 1259 | 10.3390/diagnostics11071259 |
| Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: A modelling study, France, May to September 2021 | Kiem C.T. et al. | 2021 | Eurosurveillance 5 (13) | 10.2807/1560-7917.ES.2021.26.26.2100533 |
| Benefits and risks associated with different uses of the COVID-19 vaccine Vaxzevria: a modelling study, France, May to September 2021 | Tran Kiem C. et al. | 2021 | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 26 (26) | 10.2807/1560-7917.ES.2021.26.26.2100533 |
| A review and agenda for integrated disease models including social and behavioural factors | Bedson J. et al. | 2021 | Nature Human Behaviour 5 (7), pp. 834-846 | 10.1038/s41562-021-01136-2 |
| SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse | Konings F. et al. | 2021 | Nature Microbiology 6 (7), pp. 821-823 | 10.1038/s41564-021-00932-w |
| Effectiveness of anaesthesia ventilator use for mechanical ventilation in critically ill patients during the COVID-19 pandemic | Gouel-Cheron A. et al. | 2021 | British Journal of Anaesthesia 127 (1), pp. e35-e37 | 10.1016/j.bja.2021.04.001 |
| Absence of association between 2019-20 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020 | Kissling E. et al. | 2021 | Influenza and other Respiratory Viruses 15 (4), pp. 429-438 | 10.1111/irv.12839 |
| Interoperable medical data: The missing link for understanding COVID-19 | Bauer D.C. et al. | 2021 | Transboundary and Emerging Diseases 68 (4), pp. 1753-1760 | 10.1111/tbed.13892 |
| COVID-Align: Accurate online alignment of hCoV-19 genomes using a profile HMM | Lemoine F. ; Blassel L. ; Voznica J. ; Gascuel O. | 2021 | Bioinformatics 37 (12), pp. 1761-1762 | 10.1093/bioinformatics/btaa871 |
| Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry | Firpo M.R. et al. | 2021 | ACS Infectious Diseases 7 (6), pp. 1423-1432 | 10.1021/acsinfecdis.0c00491 |
| COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters | de Melo G.D. et al. | 2021 | Science Translational Medicine 13 (596), eabf8396 | 10.1126/scitranslmed.abf8396 |
| Evolution of outcomes for patients hospitalised during the first 9 months of the SARS-CoV-2 pandemic in France: A retrospective national surveillance data analysis | Lefrancq N. et al. | 2021 | The Lancet Regional Health - Europe 5, 100087 | 10.1016/j.lanepe.2021.100087 |
| Lockdown as a last resort option in case of COVID-19 epidemic rebound: A modelling study | Kiem C.T. et al. | 2021 | Eurosurveillance 26 (22) | 10.2807/1560-7917.ES.2021.26.22.2001536 |
| Ivermectin as a potential treatment for covid-19? | Chosidow O. et al. | 2021 | PLoS Neglected Tropical Diseases 15 (6), e0009446 | 10.1371/journal.pntd.0009446 |
| The heterogeneous landscape and early evolution of pathogen-associated CpG dinucleotides in SARS-CoV-2 | Di Gioacchino A. et al. | 2021 | Molecular Biology and Evolution 38 (6), pp. 2428-2445 | 10.1093/molbev/msab036 |
| COVID-19 containment measures and incidence of invasive bacterial disease | Smith D.R.M. ; Opatowski L. | 2021 | The Lancet Digital Health 3 (6), pp. e331-e332 | 10.1016/S2589-7500(21)00085-6 |
| Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data | Brueggemann A.B. et al. | 2021 | The Lancet Digital Health 3 (6), pp. e360-e370 | 10.1016/S2589-7500(21)00077-7 |
| Diversity in immunogenomics: the value and the challenge | Peng K. et al. | 2021 | Nature Methods 18 (6), pp. 588-591 | 10.1038/s41592-021-01169-5 |
| Structural basis for broad coronavirus neutralization | Sauer M.M. et al. | 2021 | Nature Structural and Molecular Biology 28 (6), pp. 478-486 | 10.1038/s41594-021-00596-4 |
| Monitoring the proportion of the population infected by SARS-CoV-2 using age-stratified hospitalisation and serological data: a modelling study | Hozé N. et al. | 2021 | The Lancet Public Health 6 (6), pp. e408-e415 | 10.1016/S2468-2667(21)00064-5 |
| Do not neglect SARS-CoV-2 hospitalization and fatality risks in the middle-aged adult population | Lapidus N. et al. | 2021 | Infectious Diseases Now 51 (4), pp. 380-382 | 10.1016/j.idnow.2020.12.007 |
| High neutralizing potency of swine glyco-humanized polyclonal antibodies against SARS-CoV-2 | Vanhove B. et al. | 2021 | European Journal of Immunology 51 (6), pp. 1412-1422 | 10.1002/eji.202049072 |
| Oral ivermectin for a scabies outbreak in a long-term care facility: potential value in preventing COVID-19 and associated mortality | Bernigaud C. et al. | 2021 | British Journal of Dermatology 184 (6), pp. 1207-1209 | 10.1111/bjd.19821 |
| Heat inactivation of the severe acute respiratory syndrome coronavirus 2 | Batéjat C. ; Grassin Q. ; Manuguerra J.C. ; Leclercq I. | 2021 | Journal of Biosafety and Biosecurity 3 (1), pp. 1-3 | 10.1016/j.jobb.2020.12.001 |
| Fungal infections should be part of the core outcome set for COVID-19 | Verweij P.E. ; Alanio A. | 2021 | The Lancet Infectious Diseases 21 (6), pp. e145 | 10.1016/S1473-3099(20)30591-0 |
| High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households | Fritz M. et al. | 2021 | One Health 11, 100192 | 10.1016/j.onehlt.2020.100192 |
| Ousted health care workers because of COVID-19 infection: Back to work is not an easy move | GOUEL-CHERON A. ; DEN BERGH M.V. ; CRESTANI B. ; MONTRAVERS P. | 2021 | Anaesthesia Critical Care and Pain Medicine 40 (3), 100752 | 10.1016/j.accpm.2020.09.008 |
| Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies | Dufloo J. et al. | 2021 | Cell Reports Medicine 2 (5), 100275 | 10.1016/j.xcrm.2021.100275 |
| Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives | Le Hingrat Q. et al. | 2021 | Clinical Microbiology and Infection 27 (5), pp. 789.e1-789.e5 | 10.1016/j.cmi.2020.11.025 |
| Complement inhibition in severe COVID-19 – Blocking C5a seems to be key: Author's reply | Annane D. ; Grimaldi-Bensouda L. ; Fremeaux-Bacchic V. | 2021 | EClinicalMedicine 35, 100866 | 10.1016/j.eclinm.2021.100866 |
| Are posterior oropharyngeal saliva specimens an acceptable alternative to nasopharyngeal sampling for the monitoring of sars-cov-2 in primary-care settings? | Masse S. et al. | 2021 | Viruses 13 (5), 761 | 10.3390/v13050761 |
| Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies | Planas D. et al. | 2021 | Nature Medicine 27 (5), pp. 917-924 | 10.1038/s41591-021-01318-5 |
| High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers - The CoV-CONTACT cohort | Tubiana S. et al. | 2021 | Journal of Infection 82 (5), pp. 186-230 | 10.1016/j.jinf.2021.01.026 |
| Arterial abnormalities identified in kidneys transplanted into children during the COVID-19 pandemic | Berteloot L. et al. | 2021 | American Journal of Transplantation 21 (5), pp. 1937-1943 | 10.1111/ajt.16464 |
| Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: a French multicentric retrospective cohort | Dellière S. et al. | 2021 | Clinical Microbiology and Infection 27 (5), pp. 790.e1-790.e5 | 10.1016/j.cmi.2020.12.005 |
| N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2 | McCallum M. et al. | 2021 | Cell 184 (9), pp. 2332-2347.e16 | 10.1016/j.cell.2021.03.028 |
| Virology | Saleh M.C. ; Rey F.A. | 2021 | Virology , pp. 1-368 | 10.1002/9781119818526 |
| SARS-CoV-2-related MIS-C: A key to the viral and genetic causes of Kawasaki disease? | Sancho-Shimizu V. et al. | 2021 | Journal of Experimental Medicine 218 (6), e20210446 | 10.1084/jem.20210446 |
| Stealth Fluorescence Labeling for Live Microscopy Imaging of mRNA Delivery | Baladi T. et al. | 2021 | Journal of the American Chemical Society 143 (14), pp. 5413-5424 | 10.1021/jacs.1c00014 |
| Linked transmission chains of imported SARS-CoV-2 variant B.1.351 across mainland France, January 2021 | Calba C. et al. | 2021 | Eurosurveillance 26 (13) | 10.2807/1560-7917.ES.2021.26.13.2100333 |
| Fast and efficient purification of SARS-CoV-2 RNA dependent RNA polymerase complex expressed in Escherichia coli | Madru C. et al. | 2021 | PLoS ONE 16 (4 April), e0250610 | 10.1371/journal.pone.0250610 |
| Virus eradication and synthetic biology: Changes with sars-cov-2? | Tournier J.N. ; Kononchik J. | 2021 | Viruses 13 (4), 569 | 10.3390/v13040569 |
| Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020 | Sermet-Gaudelus I. et al. | 2021 | Eurosurveillance 26 (13), 2001782 | 10.2807/1560-7917.ES.2021.26.13.2001782 |
| SARS-CoV-2 population-based seroprevalence studies in Europe: A scoping review | Grant R. et al. | 2021 | BMJ Open 11 (4), e045425 | 10.1136/bmjopen-2020-045425 |
| Outcome of asymptomatic patients with positive SARS-CoV-2 viral RNA reverse transcriptase-PCR undergoing surgery: A matched cohort study | Verliere A. et al. | 2021 | European Journal of Anaesthesiology 38 (4), pp. 442-444 | 10.1097/EJA.0000000000001426 |
| Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia | de Prost N. et al. | 2021 | Journal of Clinical Immunology 41 (3), pp. 536-544 | 10.1007/s10875-021-00994-9 |
| Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study | Roederer T. et al. | 2021 | The Lancet Public Health 6 (4), pp. e202-e209 | 10.1016/S2468-2667(21)00001-3 |
| Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, France | Toubiana J. et al. | 2021 | Journal of Clinical Immunology 41 (3), pp. 526-535 | 10.1007/s10875-020-00941-0 |
| The presence of Pneumocystis jirovecii in critically ill patients with COVID-19 | Alanio A. ; Dellière S. ; Voicu S. ; Bretagne S. ; Mégarbane B. | 2021 | Journal of Infection 82 (4), pp. 84-123 | 10.1016/j.jinf.2020.10.034 |
| Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19 | Issa H. et al. | 2021 | Frontiers in Medicine 8, 620990 | 10.3389/fmed.2021.620990 |
| SARS-CoV-2 viral dynamics in non-human primates | Gonçalves A. et al. | 2021 | PLoS Computational Biology 17 (3), e1008785 | 10.1371/JOURNAL.PCBI.1008785 |
| Genomic characterization and phylogenetic analysis of the first SARS-CoV-2 variants introduced in Lebanon | Feghali R. et al. | 2021 | PeerJ 9, 11015 | 10.7717/peerj.11015 |
| SARS-CoV-2 variants and ending the COVID-19 pandemic | Fontanet A. et al. | 2021 | The Lancet 397 (10278), pp. 952-954 | 10.1016/S0140-6736(21)00370-6 |
| Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021 | Gaymard A. et al. | 2021 | Eurosurveillance 26 (9) | 10.2807/1560-7917.ES.2021.26.9.2100133 |
| Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection | Brouwer P.J.M. et al. | 2021 | Cell 184 (5), pp. 1188-1200.e19 | 10.1016/j.cell.2021.01.035 |
| Maturation and persistence of the anti-SARS-CoV-2 memory B cell response | Sokal A. et al. | 2021 | Cell 184 (5), pp. 1201-1213.e14 | 10.1016/j.cell.2021.01.050 |
| Association of Intravenous Immunoglobulins plus Methylprednisolone vs Immunoglobulins Alone with Course of Fever in Multisystem Inflammatory Syndrome in Children | Ouldali N. et al. | 2021 | JAMA - Journal of the American Medical Association 325 (9), pp. 855-864 | 10.1001/jama.2021.0694 |
| Transmission Routes of Severe Acute Respiratory Syndrome Coronavirus 2 among Healthcare Workers of a French University Hospital in Paris, France | Contejean A. et al. | 2021 | Open Forum Infectious Diseases 8 (3) | 10.1093/ofid/ofab054 |
| Very little influenza in the WHO European Region during the 2020/21 season, weeks40 2020 to 8 2021 | Adlhoch C. et al. | 2021 | Eurosurveillance 26 (11), pp. 1-8 | 10.2807/1560-7917.ES.2021.26.11.2100221 |
| A self-assessment web-based app to assess trends of the COVID-19 pandemic in France: Observational study | Denis F. et al. | 2021 | Journal of Medical Internet Research 23 (3), e26182 | 10.2196/26182 |
| Is This a Healthy Scientific Controversy or the "savior" Syndrome at Play? COVID-19 and the Hydroxychloroquine Example | Boneca I.G. | 2021 | Microbial Drug Resistance 27 (3), pp. 279-280 | 10.1089/mdr.2021.29001.igb |
| Factors associated with severe SARS-CoV-2 infection | Ouldali N. et al. | 2021 | Pediatrics 147 (3), e2020023432 | 10.1542/PEDS.2020-023432 |
| COVID-19 Job Exposure Matrix From the Mat-O-Covid Design to Its Execution | Fadel M. ; Salomon J. ; Descatha A. | 2021 | Journal of Occupational and Environmental Medicine 63 (3), pp. E168 | 10.1097/JOM.0000000000002148 |
| COVID-19 vaccination for cancer patients: Medical and ethical need | Spano J.P. ; Barre-Sinoussi F. ; Kieny M.P. ; Marcelin A.G. ; Blay J.Y. | 2021 | Bulletin du Cancer 108 (3), pp. 225-227 | 10.1016/j.bulcan.2021.02.001 |
| Parallel trends in the transmission of SARS-CoV-2 and retail/recreation and public transport mobility during non-lockdown periods | Cazelles B. ; Comiskey C. ; Nguyen-Van-Yen B. ; Champagne C. ; Roche B. | 2021 | International Journal of Infectious Diseases 104, pp. 693-695 | 10.1016/j.ijid.2021.01.067 |
| Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine | Plaze M. et al. | 2021 | International Journal of Antimicrobial Agents 57 (3), 106274 | 10.1016/j.ijantimicag.2020.106274 |
| To quarantine, or not to quarantine: A theoretical framework for disease control via contact tracing | Lunz D. ; Batt G. ; Ruess J. | 2021 | Epidemics 34, 100428 | 10.1016/j.epidem.2020.100428 |
| Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2 | Fertitta L. et al. | 2021 | Journal of the European Academy of Dermatology and Venereology 35 (3), pp. e164-e167 | 10.1111/jdv.16972 |
| Biostatistics to better detect fishy findings | Tarantola A. ; Gautier L. | 2021 | The Lancet Infectious Diseases 21 (3), pp. 316-317 | 10.1016/S1473-3099(20)30557-0 |
| Recovery of a triazole-resistant Aspergillus fumigatus in respiratory specimen of COVID-19 patient in ICU – A case report | Ghelfenstein-Ferreira T. et al. | 2021 | Medical Mycology Case Reports 31, pp. 15-18 | 10.1016/j.mmcr.2020.06.006 |
| Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A | White K.M. et al. | 2021 | Science 371 (6532), pp. 926-931 | 10.1126/science.abf4058 |
| Covid-19: Keeping schools as safe as possible | Fontanet A. ; Grant R. ; Greve-Isdahl M. ; Sridhar D. | 2021 | The BMJ 372, n524 | 10.1136/bmj.n524 |
| Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models | Ku M.W. et al. | 2021 | Cell Host and Microbe 29 (2), pp. 236-249.e6 | 10.1016/j.chom.2020.12.010 |
| The hygiene hypothesis, the COVID pandemic, and consequences for the human microbiome | Brett Finlay B. et al. | 2021 | Proceedings of the National Academy of Sciences of the United States of America 118 (6), e2010217118 | 10.1073/pnas.2010217118 |
| Age-specific mortality and immunity patterns of SARS-CoV-2 | O’Driscoll M. et al. | 2021 | Nature 590 (7844), pp. 140-145 | 10.1038/s41586-020-2918-0 |
| Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study | Rosado J. et al. | 2021 | The Lancet Microbe 2 (2), pp. e60-e69 | 10.1016/S2666-5247(20)30197-X |
| Persistent bilateral Tapia syndrome following critical COVID-19 | Yatim N. ; Bonnet N. ; Wing Tin S.N. ; Cohen Y. ; Degos B. | 2021 | Clinical Neurophysiology 132 (2), pp. 505-506 | 10.1016/j.clinph.2020.12.007 |
| Institut Pasteur International Network's efforts to guide control measures against the coronavirus disease 2019 (COVID-19) epidemic among healthcare workers in Africa | Randremanana R. et al. | 2021 | International Journal of Infectious Diseases 103, pp. 525-526 | 10.1016/j.ijid.2020.12.032 |
| Usefulness of Plasma SARS-CoV-2 RNA Quantification by Droplet-based Digital PCR to Monitor Treatment Against COVID-19 in a B-cell Lymphoma Patient | Szwebel T.A. et al. | 2021 | Stem Cell Reviews and Reports 17 (1), pp. 296-299 | 10.1007/s12015-020-10107-5 |
| When Therapeutic IgA Antibodies Might Come of Age | Sterlin D. ; Gorochov G. | 2021 | Pharmacology 106 (1-2), pp. 9-19 | 10.1159/000510251 |
| Evaluating the motivation of Red Cross Health volunteers in the COVID-19 pandemic: A mixed-methods study protocol | Heyerdahl L.W. et al. | 2021 | BMJ Open 11 (1), e042579 | 10.1136/bmjopen-2020-042579 |
| IgA dominates the early neutralizing antibody response to SARS-CoV-2 | Sterlin D. et al. | 2021 | Science Translational Medicine 13 (577), eabd2223 | 10.1126/scitranslmed.abd2223 |
| Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions among Healthcare Workers of Adult and Pediatric Settings in Central Paris | Contejean A. et al. | 2021 | Clinical Infectious Diseases 72 (2), pp. 257-264 | 10.1093/cid/ciaa977 |
| Early phylodynamics analysis of the COVID-19 epidemic in France | Danesh G. et al. | 2021 | Peer Community Journal 1, e45 | 10.24072/pcjournal.40 |
| Urban-Rural Disparities for COVID-19: Evidence from 10 Countries and Areas in the Western Pacific | Park M. ; Lim J.T. ; Wang L. ; Cook A.R. ; Dickens B.L. | 2021 | Health Data Science 2021, 9790275 | 10.34133/2021/9790275 |
| Use of lentiviral vectors in vaccination | Ku M.W. ; Charneau P. ; Majlessi L. | 2021 | Expert Review of Vaccines 20 (12), pp. 1571-1586 | 10.1080/14760584.2021.1988854 |
| Membraneless organelles restructured and built by pandemic viruses: HIV-1 and SARS-CoV-2 | Scoca V. ; Di Nunzio F. | 2021 | Journal of Molecular Cell Biology 13 (4), pp. 259-268 | 10.1093/jmcb/mjab020 |
| Origin, evolution and global spread of SARS-CoV-2 | Zhukova A. et al. | 2021 | Comptes Rendus - Biologies 344 (1), pp. 57-75 | 10.5802/CRBIOL.29 |
| Structure-function relations of the sars-cov-2 spike protein and impact of mutations in the variants of concern | Rey F. | 2021 | Comptes Rendus - Biologies 344 (1), pp. 77-110 | 10.5802/CRBIOL.53 |
| SARS-CoV-2 infection in schools in a northern French city: A retrospective serological cohort study in an area of high transmission, France, January to April 2020 | Fontanet A. et al. | 2021 | Eurosurveillance 26 (15), pp. 1-12 | 10.2807/1560-7917.ES.2021.26.15.2001695 |
| Improving care of migrants is key for viral hepatitis elimination in europe | Kim J.U. ; Ingiliz P. ; Shimakawa Y. ; Lemoine M. | 2021 | Bulletin of the World Health Organization 99 (4), pp. 280-286 | 10.2471/BLT.20.260919 |
| SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota | Sokol H. et al. | 2021 | Gut Microbes 13 (1), pp. 1-19 | 10.1080/19490976.2021.1893113 |
| Addressing vulnerabilities in communities facing infectious disease threats: A need for social science-driven assessments | Osborne J. et al. | 2021 | Journal of Global Health 11, pp. 1-4 | 10.7189/jogh.11.03003 |
| A Conceptual Discussion about the Basic Reproduction Number of Severe Acute Respiratory Syndrome Coronavirus 2 in Healthcare Settings | Temime L. et al. | 2021 | Clinical Infectious Diseases 72 (1), pp. 141-143 | 10.1093/cid/ciaa682 |
| Correction to: IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 (Journal of Clinical Immunology, (2021), 41, 1, (26-27), 10.1007/s10875-020-00933-0) | Lévy R. et al. | 2021 | Journal of Clinical Immunology 41 (1), pp. 28 | 10.1007/s10875-021-00969-w |
| Impact of the lockdown on the burden of COVID-19 in outpatient care in France, spring 2020 | Souty C. et al. | 2021 | Infectious Diseases 53 (5), pp. 376-381 | 10.1080/23744235.2021.1880024 |
| Performing point-of-care molecular testing for SARS-CoV-2 with RNA extraction and isothermal amplification | Garneret P. et al. | 2021 | PLoS ONE 16 (1 January), e0243712 | 10.1371/journal.pone.0243712 |
| Gastrointestinal Symptoms Followed by Shock in a Febrile 7-Year-Old Child during the COVID-19 Pandemic | Allali S. ; Cohen J.F. ; Brice J. ; Khraiche D. ; Toubiana J. | 2021 | Clinical Chemistry 67 (1), pp. 54-58 | 10.1093/clinchem/hvaa279 |
| IFN-α2a Therapy in Two Patients with Inborn Errors of TLR3 and IRF3 Infected with SARS-CoV-2 | Lévy R. et al. | 2021 | Journal of Clinical Immunology 41 (1), pp. 26-27 | 10.1007/s10875-020-00933-0 |
| High seroprevalence but short-lived immune response to SARS-CoV-2 infection in Paris | Anna F. et al. | 2021 | European Journal of Immunology 51 (1), pp. 180-190 | 10.1002/eji.202049058 |
| Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic | Baay M. et al. | 2021 | Biologicals 69, pp. 76-82 | 10.1016/j.biologicals.2020.11.003 |
| Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on “Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome” by Quartuccio et al. Joint Bone Spine. 2020;87:191–93 | Vieira M. et al. | 2021 | Joint Bone Spine 88 (1), 105074 | 10.1016/j.jbspin.2020.09.006 |
| An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike | Schoof M. et al. | 2020 | Science 370 (6523), pp. 1473-1479 | 10.1126/science.abe3255 |
| Reconstruction of Transmission Pairs for Novel Coronavirus Disease 2019 (COVID-19) in Mainland China: Estimation of Superspreading Events, Serial Interval, and Hazard of Infection | Xu X.K. et al. | 2020 | Clinical Infectious Diseases 71 (12), pp. 3163-3167 | 10.1093/cid/ciaa790 |
| Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms | Gordon D.E. et al. | 2020 | Science 370 (6521), eabe9403 | 10.1126/science.abe9403 |
| Association between SARS-CoV-2 infection and Kawasaki-like multisystem inflammatory syndrome: A retrospective matched case–control study, Paris, France, April to May 2020 | Toubiana J. et al. | 2020 | Eurosurveillance 25 (48) | 10.2807/1560-7917.ES.2020.25.48.2001813 |
| Impact of mass testing during an epidemic rebound of SARS-CoV-2: A modelling study using the example of France | Bosetti P. et al. | 2020 | Eurosurveillance 26 (1) | 10.2807/1560-7917.ES.2020.26.1.2001978 |
| Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus | Cocozza F. et al. | 2020 | Journal of Extracellular Vesicles 10 (2), e12050 | 10.1002/jev2.12050 |
| The Importance of Biobanking for Response to Pandemics Caused by Emerging Viruses: The European Virus Archive As an Observatory of the Global Response to the Zika Virus and COVID-19 Crisis | Coutard B. et al. | 2020 | Biopreservation and Biobanking 18 (6), pp. 561-569 | 10.1089/bio.2020.0119 |
| Optimizing COVID-19 surveillance in long-term care facilities: a modelling study | Smith D.R.M. et al. | 2020 | BMC Medicine 18 (1), 386 | 10.1186/s12916-020-01866-6 |
| A comparison of non-magnetic and magnetic beads for measuring IgG antibodies against Plasmodium vivax antigens in a multiplexed bead-based assay using Luminex technology (Bio-Plex 200 or MAGPIX) | Mazhari R. et al. | 2020 | PLoS ONE 15 (12 December), e0238010 | 10.1371/journal.pone.0238010 |
| What causes hidradenitis suppurativa ?—15 years after | Zouboulis C.C. et al. | 2020 | Experimental Dermatology 29 (12), pp. 1154-1170 | 10.1111/exd.14214 |
| Survival of the Wealthiest? | Garfinkel M. ; Sansonetti P.J. ; Pulverer B. | 2020 | EMBO Journal 39 (23), e107227 | 10.15252/embj.2020107227 |
| Anti-infective therapy against SARS-CoV-2: some light at the end of the tunnel? | Montravers P. ; Kantor E. ; Gouel-Cheron A. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (6), pp. 695-697 | 10.1016/j.accpm.2020.10.004 |
| Syncytia formation by SARS-CoV-2-infected cells | Buchrieser J. et al. | 2020 | EMBO Journal 39 (23), e106267 | 10.15252/embj.2020106267 |
| Complement C5 inhibition in patients with COVID-19 - A promising target? | de Latour R.P. et al. | 2020 | Haematologica 105 (12), pp. 2847-2850 | 10.3324/haematol.2020.260117 |
| A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity | Huang A.T. et al. | 2020 | Nature Communications 11 (1), 4704 | 10.1038/s41467-020-18450-4 |
| Absence of SARS-CoV-2 infection in cats and dogs in close contact with a cluster of COVID-19 patients in a veterinary campus | Temmam S. et al. | 2020 | One Health 10, 100164 | 10.1016/j.onehlt.2020.100164 |
| SARS-CoV-2 natural transmission from human to Cat, Belgium, March 2020 | Garigliany M. et al. | 2020 | Emerging Infectious Diseases 26 (12), pp. 3069-3071 | 10.3201/EID2612.202223 |
| Author Correction: COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms (Scientific Data, (2020), 7, 1, (136), 10.1038/s41597-020-0477-8) | Ostaszewski M. et al. | 2020 | Scientific Data 7 (1), 247 | 10.1038/s41597-020-00589-w |
| COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms | Ostaszewski M. et al. | 2020 | Scientific Data 7 (1), 136 | 10.1038/s41597-020-0477-8 |
| Epidemiological data from the COVID-19 outbreak, real-time case information | Xu B. et al. | 2020 | Scientific Data 7 (1), 106 | 10.1038/s41597-020-0448-0 |
| Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms | Tortorici M.A. et al. | 2020 | Science 370 (6519), pp. 950-957 | 10.1126/science.abe3354 |
| Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology | Piccoli L. et al. | 2020 | Cell 183 (4), pp. 1024-1042.e21 | 10.1016/j.cell.2020.09.037 |
| Implementation of a self-triage web application for suspected COVID-19 and its impact on emergency call centers: Observational study | Galmiche S. et al. | 2020 | Journal of Medical Internet Research 22 (11), e22924 | 10.2196/22924 |
| COVID-19 and vaccination: A global disruption | Billon-Denis E. ; Tournier J.N. | 2020 | Medecine/Sciences 36 (11), pp. 1034-1037 | 10.1051/medsci/2020203 |
| Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study | Annane D. et al. | 2020 | EClinicalMedicine 28, 100590 | 10.1016/j.eclinm.2020.100590 |
| Brief comparative evaluation of six open one-step RT-qPCR mastermixes for the detection of SARS-CoV-2 RNA using a Taqman probe | Haddar C. ; Verhoeven P.O. ; Bourlet T. ; Pozzetto B. ; Pillet S. | 2020 | Journal of Clinical Virology 132, 104636 | 10.1016/j.jcv.2020.104636 |
| Effect of the COVID-19 pandemic on viral hepatitis services in sub-Saharan Africa | Lemoine M. et al. | 2020 | The Lancet Gastroenterology and Hepatology 5 (11), pp. 966-967 | 10.1016/S2468-1253(20)30305-8 |
| Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong | Adam D.C. et al. | 2020 | Nature Medicine 26 (11), pp. 1714-1719 | 10.1038/s41591-020-1092-0 |
| A review of the main histopathological findings in coronavirus disease 2019 | Vasquez-Bonilla W.O. et al. | 2020 | Human Pathology 105, pp. 74-83 | 10.1016/j.humpath.2020.07.023 |
| Animal and translational models of SARS-CoV-2 infection and COVID-19 | Johansen M.D. et al. | 2020 | Mucosal Immunology 13 (6), pp. 877-891 | 10.1038/s41385-020-00340-z |
| First detection and genome sequencing of SARS-CoV-2 in an infected cat in France | Sailleau C. et al. | 2020 | Transboundary and Emerging Diseases 67 (6), pp. 2324-2328 | 10.1111/tbed.13659 |
| Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients | Smadja D.M. et al. | 2020 | Angiogenesis 23 (4), pp. 611-620 | 10.1007/s10456-020-09730-0 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 | Zhang Q. et al. | 2020 | Science 370 (6515), eabd4570 | 10.1126/science.abd4570 |
| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 | Bastard P. et al. | 2020 | Science 370 (6515), eabd4585 | 10.1126/science.abd4585 |
| Lockdown impact on COVID-19 epidemics in regions across metropolitan France | Cauchemez S. ; Kiem C.T. ; Paireau J. ; Rolland P. ; Fontanet A. | 2020 | The Lancet 396 (10257), pp. 1068-1069 | 10.1016/S0140-6736(20)32034-1 |
| No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation | Cappy P. et al. | 2020 | Blood 136 (16), pp. 1888-1891 | 10.1182/BLOOD.2020008230 |
| COVID-19 herd immunity: where are we? | Fontanet A. ; Cauchemez S. | 2020 | Nature Reviews Immunology 20 (10), pp. 583-584 | 10.1038/s41577-020-00451-5 |
| Monitoring approaches for health-care workers during the COVID-19 pandemic | Bielicki J.A. et al. | 2020 | The Lancet Infectious Diseases 20 (10), pp. e261-e267 | 10.1016/S1473-3099(20)30458-8 |
| Rapid Genomic Characterization of SARS-CoV-2 by Direct Amplicon-Based Sequencing Through Comparison of MinION and Illumina iSeq100TM System | Hourdel V. et al. | 2020 | Frontiers in Microbiology 11, 571328 | 10.3389/fmicb.2020.571328 |
| Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates | Maisonnasse P. et al. | 2020 | Nature 585 (7826), pp. 584-587 | 10.1038/s41586-020-2558-4 |
| Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19 | Silvin A. et al. | 2020 | Cell 182 (6), pp. 1401-1418.e18 | 10.1016/j.cell.2020.08.002 |
| A comprehensive, flexible collection of SARS-CoV-2 coding regions | Kim D.K. et al. | 2020 | G3: Genes, Genomes, Genetics 10 (9), pp. 3399-3402 | 10.1534/g3.120.401554 |
| Modeling the inactivation of viruses from the Coronaviridae family in response to temperature and relative humidity in suspensions or on surfaces | Guillier L. et al. | 2020 | Applied and Environmental Microbiology 86 (18), e01244 | 10.1128/AEM.01244-20 |
| COVID-19 in Patients on Maintenance Dialysis in the Paris Region | Tortonese S. et al. | 2020 | Kidney International Reports 5 (9), pp. 1535-1544 | 10.1016/j.ekir.2020.07.016 |
| Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France | Fafi-Kremer S. et al. | 2020 | EBioMedicine 59, 102915 | 10.1016/j.ebiom.2020.102915 |
| Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis | Ouldali N. et al. | 2020 | The Lancet Child and Adolescent Health 4 (9), pp. 662-668 | 10.1016/S2352-4642(20)30175-9 |
| Reducing antibiotic prescribing and addressing the global problem of antibiotic resistance by targeted hygiene in the home and everyday life settings: A position paper | Maillard J.Y. et al. | 2020 | American Journal of Infection Control 48 (9), pp. 1090-1099 | 10.1016/j.ajic.2020.04.011 |
| Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions | Ali S.T. et al. | 2020 | Science 369 (6507), pp. 1106-1109 | 10.1126/science.abc9004 |
| Characterization of accessory genes in coronavirus genomes | Michel C.J. ; Mayer C. ; Poch O. ; Thompson J.D. | 2020 | Virology Journal 17 (1), 131 | 10.1186/s12985-020-01402-1 |
| Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients | Hadjadj J. et al. | 2020 | Science 369 (6504), pp. 718-724 | 10.1126/science.abc6027 |
| The Global Phosphorylation Landscape of SARS-CoV-2 Infection | Bouhaddou M. et al. | 2020 | Cell 182 (3), pp. 685-712.e19 | 10.1016/j.cell.2020.06.034 |
| A race against the clock: Creation of SARS-CoV-2 in the laboratory, a month after its emergence! | Iseni F. ; Tournier J.N. | 2020 | Medecine/Sciences 36 (8-9), pp. 797-801 | 10.1051/medsci/2020124 |
| An Old Cytokine against a New Virus | Pellegrini S. ; Uzé G. | 2020 | Journal of Interferon and Cytokine Research 40 (8), pp. 425-428 | 10.1089/jir.2020.0130 |
| Structural insight into the role of novel SARSCoV-2 E protein: A potential target for vaccine development and other therapeutic strategies | Sarkar M. ; Saha S. | 2020 | PLoS ONE 15 (8 August), e0237300 | 10.1371/journal.pone.0237300 |
| Delayed laboratory response to COVID-19 caused by molecular diagnostic contamination | Mögling R. et al. | 2020 | Emerging Infectious Diseases 26 (8), pp. 1944-1946 | 10.3201/eid2608.201843 |
| Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): A multicentre cohort | Pouletty M. et al. | 2020 | Annals of the Rheumatic Diseases 79 (8), pp. 999-1006 | 10.1136/annrheumdis-2020-217960 |
| Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion | Verweij P.E. et al. | 2020 | Intensive Care Medicine 46 (8), pp. 1524-1535 | 10.1007/s00134-020-06091-6 |
| Minimising COVID-19 exposure during tracheal intubation by using a transparent plastic box: A randomised prospective simulation study | Clariot S. ; Dumain G. ; Gauci E. ; Langeron O. ; Levesque É. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (4), pp. 461-463 | 10.1016/j.accpm.2020.06.005 |
| A SARS-CoV-2 protein interaction map reveals targets for drug repurposing | Gordon D.E. et al. | 2020 | Nature 583 (7816), pp. 459-468 | 10.1038/s41586-020-2286-9 |
| Estimating the burden of SARS-CoV-2 in France | Salje H. et al. | 2020 | Science 369 (6500), pp. 208-211 | 10.1126/science.abc3517 |
| Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody | Pinto D. et al. | 2020 | Nature 583 (7815), pp. 290-295 | 10.1038/s41586-020-2349-y |
| Interplay between SARS-CoV-2 and the type I interferon response | Ribero M.S. ; Jouvenet N. ; Dreux M. ; Nisole S. | 2020 | PLoS Pathogens 16 (7), e1008737 | 10.1371/journal.ppat.1008737 |
| Knowledge, attitude, and perceptions towards the 2019 Coronavirus Pandemic: A bi-national survey in Africa | Hager E. et al. | 2020 | PLoS ONE 15 (7 July), e0236918 | 10.1371/journal.pone.0236918 |
| Planetary health: young academics ask universities to act | Wabnitz K.J. et al. | 2020 | The Lancet Planetary Health 4 (7), pp. e257-e258 | 10.1016/S2542-5196(20)30142-X |
| SARS-CoV-2: Virology, epidemiology, immunology and vaccine development | Baay M. et al. | 2020 | Biologicals 66, pp. 35-40 | 10.1016/j.biologicals.2020.06.005 |
| A hybrid approach to tracheostomy in COVID-19 patients ensuring staff safety | Tanaka L. et al. | 2020 | British Journal of Surgery 107 (8), pp. e253-e254 | 10.1002/bjs.11705 |
| Working from home in the time of COVID-19: How to best preserve occupational health? | Bouziri H. et al. | 2020 | Occupational and Environmental Medicine 77 (7), pp. 509-510 | 10.1136/oemed-2020-106599 |
| Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients | Bost P. et al. | 2020 | Cell 181 (7), pp. 1475-1488.e12 | 10.1016/j.cell.2020.05.006 |
| Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable | Mavian C. et al. | 2020 | Proceedings of the National Academy of Sciences of the United States of America 117 (23), pp. 12522-12523 | 10.1073/pnas.2007295117 |
| Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study | Toubiana J. et al. | 2020 | BMJ (Clinical research ed.) 369, pp. m2094 | 10.1136/bmj.m2094 |
| Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study | Plaze M. et al. | 2020 | Encephale 46 (3), pp. S35-S39 | 10.1016/j.encep.2020.04.010 |
| French psychiatry and the novelty of the COVID-19 crisis | Masson M. ; Gaillard R. | 2020 | Encephale 46 (3), pp. S1-S2 | 10.1016/j.encep.2020.06.001 |
| Epidemiological Observations on the Association between Anosmia and COVID-19 Infection: Analysis of Data from a Self-Assessment Web Application | Denis F. et al. | 2020 | Journal of Medical Internet Research 22 (6), e19855 | 10.2196/19855 |
| Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19 | Alanio A. ; Dellière S. ; Fodil S. ; Bretagne S. ; Mégarbane B. | 2020 | The Lancet Respiratory Medicine 8 (6), pp. e48-e49 | 10.1016/S2213-2600(20)30237-X |
| Repurposing chlorpromazine to treat COVID-19: The reCoVery study | Plaze M. et al. | 2020 | Encephale 46 (3), pp. 169-172 | 10.1016/j.encep.2020.05.006 |
| Frequently asked questions regarding SARS-CoV-2 in cancer patients—recommendations for clinicians caring for patients with malignant diseases | von Lilienfeld-Toal M. et al. | 2020 | Leukemia 34 (6), pp. 1487-1494 | 10.1038/s41375-020-0832-y |
| Preliminary observations of anaesthesia ventilators use for prolonged mechanical ventilation in intensive care unit patients during the COVID-19 pandemic | Gouel-Cheron A. ; Couffignal C. ; Elmaleh Y. ; Kantor E. ; Montravers P. | 2020 | Anaesthesia Critical Care and Pain Medicine 39 (3), pp. 371-372 | 10.1016/j.accpm.2020.04.009 |
| Invasive fungal diseases during COVID-19: We should be prepared | Gangneux J.P. ; Bougnoux M.E. ; Dannaoui E. ; Cornet M. ; Zahar J.R. | 2020 | Journal de Mycologie Medicale 30 (2), 100971 | 10.1016/j.mycmed.2020.100971 |
| Clinical and virological data of the first cases of COVID-19 in Europe: a case series | Lescure F.X. et al. | 2020 | The Lancet Infectious Diseases 20 (6), pp. 697-706 | 10.1016/S1473-3099(20)30200-0 |
| Serial interval of COVID-19 among publicly reported confirmed cases | Du Z. et al. | 2020 | Emerging Infectious Diseases 26 (6), pp. 1341-1343 | 10.3201/EID2606.200357 |
| Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients | Bonam S.R. ; Kaveri S.V. ; Sakuntabhai A. ; Gilardin L. ; Bayry J. | 2020 | Cell Reports Medicine 1 (2), 100016 | 10.1016/j.xcrm.2020.100016 |
| COVID-19, chronicle of an expected pandemic | Sansonetti P.J. | 2020 | EMBO Molecular Medicine 12 (5), e12463 | 10.15252/emmm.202012463 |
| Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays | Crawford K.H.D. et al. | 2020 | Viruses 12 (5), 513 | 10.3390/v12050513 |
| The effect of human mobility and control measures on the COVID-19 epidemic in China | Kraemer M.U.G. et al. | 2020 | Science 368 (6490), pp. 493-497 | 10.1126/science.abb4218 |
| Chloroquine and COVID-19, where do we stand? | Lecuit M. | 2020 | Medecine et Maladies Infectieuses 50 (3), pp. 229-230 | 10.1016/j.medmal.2020.03.004 |
| Risk for transportation of coronavirus disease from Wuhan to other cities in China | Du Z. et al. | 2020 | Emerging Infectious Diseases 26 (5), pp. 1049-1052 | 10.3201/eid2605.200146 |
| Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein | Walls A.C. et al. | 2020 | Cell 181 (2), pp. 281-292.e6 | 10.1016/j.cell.2020.02.058 |
| Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020 | Boëlle P.Y. et al. | 2020 | Eurosurveillance 25 (14), 2000326 | 10.2807/1560-7917.ES.2020.25.14.2000326 |
| Facing challenges with the novel coronavirus SARS-CoV-2 outbreak | van der Werf S. ; Peltekian C. | 2020 | Virologie (Montrouge, France) 24 (S1), pp. e12-e15 | 10.1684/vir.2020.0826 |
| Coronavirus outbreak: the role of companies in preparedness and responses | Fadel M. ; Salomon J. ; Descatha A. | 2020 | The Lancet Public Health 5 (4), pp. e193 | 10.1016/S2468-2667(20)30051-7 |
| First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020 | Spiteri G. et al. | 2020 | Eurosurveillance 25 (9), 2000178 | 10.2807/1560-7917.ES.2020.25.9.2000178 |
| First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures, January 2020 | Stoecklin S.B. et al. | 2020 | Eurosurveillance 25 (6), 2000094 | 10.2807/1560-7917.ES.2020.25.6.2000094 |
| Development of vaccines at the time of COVID-19 | Almond J. et al. | 2020 | MicroLife 1 (1), uqaa003 | 10.1093/femsml/uqaa003 |
| COVID-19 and socioeconomic development in Africa: The first 6 months (february 2020-august 2020) | Garenne M.M. | 2020 | International Journal of Population Studies 6 (2), pp. 1-14 | 10.18063/ijps.v6i2.1222 |
| Highly performing point-of-care molecular testing for sars-cov-2 with RNA extraction and isothermal amplificaiton | Coz E. et al. | 2020 | MicroTAS 2020 - 24th International Conference on Miniaturized Systems for Chemistry and Life Sciences , pp. 1232-1233 | |
| Rapid detection of COVID-19 by serological methods and the evaluation of diagnostic efficacy of IgM and IgG | Huang S. et al. | 2020 | Clinical Laboratory 66 (11), pp. 2327-2333 | 10.7754/Clin.Lab.2020.200617 |
| Pandemic legion history more complex than previously thought | Tournier J.N. | 2020 | mBio 11 (5), e02377-20 | 10.1128/mBio.02377-20 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations | Grzelak L. et al. | 2020 | Science Translational Medicine 12 (559), eabc3103 | 10.1126/SCITRANSLMED.ABC3103 |
| Randomized controlled study evaluating efficiency of low intensity transcranial direct current stimulation (TDCS) for dyspnea relief in mechanically ventilated COVID-19 patients in ICU: The tDCS-DYSP-COVID protocol | Azabou E. et al. | 2020 | Frontiers in Medicine 7, 372 | 10.3389/fmed.2020.00372 |
| Introductions and early spread of SARS-CoV-2 in france, 24 january to 23 march 2020 | Gámbaro F. et al. | 2020 | Eurosurveillance 25 (26) | 10.2807/1560-7917.ES.2020.25.26.2001200 |
| A nicotinic hypothesis for Covid-19 with preventive and therapeutic implications | Changeux J.P. ; Amoura Z. ; Rey F.A. ; Miyara M. | 2020 | Comptes Rendus - Biologies 343 (1), pp. 33-39 | 10.5802/crbiol.8 |
The data was downloaded from Scopus API this day via https://api.elsevier.com and https://www.scopus.com.